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ABSTRACT 
Among other glial cell types such as microglia, oligodendrocytes and radial glia, 
astrocytes are known to be involved in brain function; metabolically supporting 
neurons, regulating blood flow dynamics, participating in the development of 
pathological states, sensing and modulating synaptic activity. At the same time the 
complex astrocytic morphology, with a number of highly ramified peripheral 
processes located near the synaptic terminals, suggests them as a possible source 
for morpho-functional plasticity in the brain. This thesis summarizes the work on 
the in vitro development and further in vivo implementation, using a gene delivery 
system, of a tool for suppressing activity-dependent astrocytic motility. Calcium-
induced astrocyte process outgrowth and its dependence on Profilin-1, novel in 
vivo gene delivery approaches, a demonstration of astrocytic motility in vivo and 
the independence of visual processing from astrocytic motility rates are the main 
findings of the project. The results described in this work increase our 
understanding of the interactions occurring between astrocytes and neurons as well 
as the consequences for brain function.  
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INTRODUCTION 
The general assumption that brain functionality relies exclusively on wired neurons 
is far from the truth. Among the neurons there are several other cell types that play 
essential structural and functional roles in the brain. Indeed, astroglia, microglia, 
oligodendrocytes and radial glia cells are involved in brain development, 
maintenance, re-wiring, synaptic turnover and modulation of synaptic properties 
(Nicholls et al., 2001, pp. 133-46; Volterra et al., 2002). Modulation of basal 
synaptic transmission (Navarrete and Araque, 2011), facilitation of long-term 
synaptic potentiation (Henneberger et al., 2010), regulation of neuronal network 
activity (Pannasch and Rouach, 2013) and metabolic support of neurons 
(Magistretti et al., 2006) are the main points of astrocyte and neuron interactions. 
On the other hand astrocytes are known to display a set of unique morphological 
features: occupation of non-overlapping spatial domains (Bushong et al., 2002; 
Ogata and Kosaka, 2002), forming a complex 3D network of peripheral processes 
(Witcher et al., 2007; Shigetomi et al., 2013) and their strategic positioning near 
the synaptic terminals (reviewed by Reichenbach et al., 2010) that allow us to 
propose that astrocytes are the link between structural and functional changes 
occurring in the brain. In this study we posed the questions are astrocytes in vivo 
subjected to continuous morphological changes and will the suppression of these 
changes somehow affect neuronal activity in a restricted brain region? 
REVIEW OF THE LITERATURE 
1. Different glial cell types and their role in the mammalian 
brain 
Glial cells were first described in 1840s by Rudolf Virchow (Virchow, 1846; 
Virchow, 1858), who coined a general name for them - “neuroglia”, i.e. “nerve 
glue” in 1856. Half a century later, Camillo Golgi (Golgi, 1903) in 1883 and 
Santiago Ramon y Cajal (Ramon y Cajal, 1995) in 1890s predicated that glial cells 
are more than “brain glue” and not merely metabolic suppliers for neurons. For 
many decades since, the doctrine that promotes neurons as central players of 
nervous system functionality was prevalent. Starting in the 1990’s, it became more 
and more evident that some aspects of nervous system physiology as well as 
pathophysiology could not be explained in light of exclusive neuronal doctrine, and 
the idea emerged that some glial cells might be also involved in information 
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processing within the nervous system (Kettenmann and Ransom, 1995). Glia is a 
general term for a diverse population of different non-neuronal cell types in a brain, 
including microglial cells that act as immune cells in central nervous system 
(CNS), oligodendrocytes and Schwann cells – myelinating cells, radial glia playing 
important role in brain development, NG2 and Bergman glial cells (Ransom, 
1991), and astrocytes that metabolically support neurons and are involved in 
synaptic transmission and development (Ransom, 1991; Kettenmann and Ransom, 
1995; Araque et al., 1999; Haydon, 2001) (Fig. 1). 
 
Figure 1. Different types of glial cells perform a variety of functions in the brain. Radial glia cells (black) in 
neonatal rat cortex (grays) extending their processes from lateral ventricle towards cortical surface and guiding 
neuronal precursors and other cells to their final destination during brain development (A). Myelinating 
oligodendrocyte (black) enwraps axons (grey), supports their integrity and facilitate conductance of action 
potentials (B). Highly mobile microglial cell with a number of processes is continuously probeing the surrounding 
area (C). Astroglial cell with highly ramified peripheral process associated with synapses can influence synaptic 
transmission (D). (Images modofied from Fields and Petryniak (NIH), Bouscein et al., 2003 and Shigetomi et al., 
2013). 
 
1.1 Radial glia and glial progenitor cells 
Radial glia play an important role in guiding neuronal progenitor cells from sub 
ventricular zone to their place of final differentiation and action. These glial cells 
have their cell bodies located in the ventricular zone and exhibit bipolar processes 
extending to reach the pial and ventricular surfaces (Fig. 1A). These type of glial 
cells are transient and present only at embryonic and early postnatal stages of brain 
development (Rowitch and Kriegstein, 2010). Radial glia cells are formed from 
neural stem cells at ventricular and sub ventricular zones and can later differentiate 
as neuronal progenitors to almost any neural cell type including ependymal cells, 
subventricular zone astrocytes, oligodendrocytes and neurons (Malatesta et al., 
2003). Notably, apart from the peculiar shape, in many species no markers are 
known that allow discrimination of radial glia from astrocytes. This is the case, for 
instance, in primates, where the immunoreactivity for GFAP is shown by both cell 
types (Choi and Kim, 1985; Choi, 1986). These cells clearly fulfill a multi-purpose 
role, contributing to the generation, migration and probably even the specification 
and/or differentiation of distinct neuronal subtypes. 
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1.2 Oligodendrocytes and Schwann cells 
Both Oligodendrocytes and Schwann cells are very specialized glial cells types that 
have reached their final differentiation step. They are formed at the latest stages of 
the nervous system development.  Oligodendrocytes are presented in a CNS where 
they myelinate several axons simultaneously (Fig. 1B) whereas Schwann cells 
were found in peripheral nervous system (PNS) where they can be associated with 
single axon or neuro-muscular junctions. One of the most important functions of 
oligodendrocytes and Schwann cells is to form a myelin sheath around axons 
(Nave, 2010). This kind of axon insulation enables rapid action potential 
propagation within thin and long mammalian axons that relies as a key concept of 
neurophysiology that providing possibility for complex and at the same time 
compact nervous system. In addition to their insulation role these cells can also 
support axonal integrity and provide functions that may be independent of myelin 
itself (Griffiths et al., 1998). Additionally myelinating glia are involved in several 
demyelinating disorders, like multiple sclerosis, leukodystrophies and 
demyelinating neuropathies (Nave, 2010). 
1.3 Microglial cells 
Microglia represents approximately 10% of total amount of cells in the mammalian 
CNS (reviewed by Kettenmann et al., 2011). They can appear as tree-like cells with 
many ramified processes (Fig. 1C) or as amoeboid cells with reduced morphology 
depending on developmental stage of the CNS and on their activation and/or 
migration status (Streit et al., 1988; Kettenmann et al., 2011). Common feature for 
all microglial cells is their high motility rates even in a resting state when changes 
occur within peripheral processes (Nimmerjahn et al., 2005). This continuous 
motility proposed to be linked with probing of perineuronal space (Kettenmann et 
al., 2013) or in case of activation could involve morphological remodeling of the 
whole cell. Both morphological changes and migration of microglial cells is 
thought to be caused by actin cytoskeleton remodeling regulated mainly via protein 
kinase C (PKC) and inositol-3-phosphate (InsP3) signaling pathways (Kettenmann 
et al., 2011). Migration of microglia in addition to their morphological changes in 
the adult CNS can be switched on by a variety of pathophysiological actions. For 
instance in laser induced brain micro lesion or thrombotic micro stroke microglial 
cells are known to extend their processes rapidly towards a lesion site or 
thrombotized blood vessels (Davalos et al., 2005). 
Functions of microglial cells are very diverse and their portfolio has been 
extensively added to during last few years. The immune status quo of the CNS 
  
4 
 
caused by blood-brain barrier (BBB) has made it necessary to have a local 
separated immune competent system within CNS. Being macrophage-like cells 
with a potential for multiple cell divisions, their major role is to be immune cells in 
the brain and therefore act as pathology sensors at the CNS. They remove apoptotic 
brain cells and cell debris by phagocytosis, are involved in response to brain 
ischemia (Kettenmann et al., 2011) and are participating in developmental as well 
as in adult brain plasticity on the level of individual synapses (Wake et al., 2013).  
Purinergic signaling mediated by ATP, which is suggested to be a major danger 
signal in the CNS, is one of the most studied and acknowledged pathways for 
triggering microglial activation, apoptosis and phagocytosis. However, there are 
many potential alternative pathways to be involved in a complex process of 
microglia interaction with other CNS cell types. Indeed, microglial cells express 
plenty of different channels on their surface including sodium channels, voltage-
dependent Ca
2+
 channels, transient receptor potential (TRP)-generating channels, 
Ca
2+
 activated and G protein activated potassium channels, volume regulated 
chloride channels and also different types of aquaporins and connexons 
(Kettenmann et al., 2011). There are also some evidences that microglial cells 
might express glutamate receptors such as AMPA receptors with low Ca
2+
 
permeability (Noda et al., 2000) and functional metabotropic glutamate receptors 
(mGluR) (Biber et al., 1999). 
First described as immune cells in the CNS that can switch between resting and 
activated states microglial functions were extended first to developmental plasticity 
by synapse stripping (Kettenmann et al., 2013) and further to a variety of roles in 
such pathologies as Alzheimer disease and psychiatric disorders (Aguzzi et al., 
2013). Without a doubt microglia have complex and important impact on the CNS 
development and function which is still enigmatic in the majority of its aspects.  
1.4 Astroglial cells (a.k.a. astrocytes) 
The name “astrocyte” stems from the stellar, or star-like, shape of the most 
numerous and best studied glial cell type in mammalian brain (Fig. 1D). There are 
probably many sub-types of astrocytes, but scientists have yet to agree on the 
classification principles that would allow distinguishing between various 
taxonomic groups within an astrocytic population. For example, anatomical 
evidence suggests that fibrous and protoplasmic astrocytes are two distinct groups 
(Penfield et al., 1932); it is not clear, however, whether the same astrocyte can 
make a transition between these two anatomical states. Furthermore, the level of 
expression of glial fibrillary acidic protein (GFAP), which is a classical astrocytic 
marker, varies in a large range between individual cells as well as between 
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different patho-physiological conditions (Chiu and Goldman, 1985; Baba et al., 
1997; Gomes et al., 1999; Messing and Brenner, 2003; Middeldorp and Hol, 2011). 
Finally, brain region-dependent specialization of astrocytes is likely to occur, and 
in some regions astrocytes even have been assigned a separate name (e.g., 
Bergmann glia in cerebellum (Bergmann, 1857)). 
Functionally, astrocytes may also be divided in a number of subtypes (although 
again, a consensus in the field is still lacking). Undoubtedly, though, functions of 
astrocytes are numerous and vary widely from vital metabolic support of neurons 
and formation of blood-brain barrier to enabling synaptogenesis and synaptic 
plasticity all the way to elimination of synapses. Some of these classical and more 
recently discovered functions will be discussed in detail in following chapters.  It 
seems important to note that, although astrocytes have been studied for decades 
(anatomically since 1850s and functionally since 1990s), their role in the CNS is 
still somewhat enigmatic as more questions arise from each new study. 
2. Astroglia functions in the brain 
2.1 Metabolic support of neurons by astrocytes 
Neurons are supposed to be the main consumers of energetic substrates over the 
mammalian body. The energy is utilized for maintenance of membrane potential in 
resting condition as well as for action potential generation during neuronal network 
electrical activity (reviewed by Magistretti, 2006; Allaman et al., 2011) and long 
term memory formation (Suzuki et al., 2011). Regional blood flow changes, energy 
and as a consequence oxygen and glucose consumption by neural tissue are related 
to neuronal activity and are used as a basis for different brain functional imaging 
techniques (Magistretti and Pellerin, 1999; Raichle and Mintun, 2006; Hyder, 
2009; Bandettini, 2012). It is a well-established fact also that, in comparison to 
other cell types, glucose is not the main energetic substrate for neurons and that 
glycolysis is much more ineffective in neurons as compared to the tricarboxylic 
acid (TCA) cycle that utilizes lactate for energy production (Pellerin et al., 2007; 
Magistretti, 2006). On the other hand astrocyte metabolism demonstrates 
remarkably more active glycolysis and provides a source of lactate for neurons. 
This metabolic complementarity is not likely to be a fortuity but a result of 
metabolic coupling between astrocytes and neurons (Magistretti, 2006). This 
neuro-glial metabolic coupling includes active transport of glucose by astrocytes 
from a blood flow, glycolysis in astrocytes and active lactate transfer from 
astrocytes to neurons in an activity-dependent manner (Volterra et al., 2002; 
Kasischke et al., 2004).  
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Glucose from blood flow is transported into astrocytes via specific glucose GLUT-
1 type transporters that are expressed in endfeet surrounding blood vessels 
(Morgello et al., 1995; Yu and Ding, 1998). This glucose is used in classical 
glycolysis that results in a anaerobic production of pyruvate and further to lactate 
in astrocytes with a muscle form of lactate dehydrogenase 5 (LDH) (Bittar et al., 
1996). Increased glucose utilization in response to glutamate uptake (Pellerin and 
Magistretti, 1994; Takahashi et al., 1995) as well as lactate production following 
sensory stimulation of neuronal activity (Fellows et al., 1993) are key signs for 
coupling between astrocytic metabolism which acts as a glutamate source and 
neuronal activity. Astrocytes can actively evacuate glutamate from active synaptic 
sites by specific excitatory amino acid transporters (EAAT) 1 and 2 (reviewed in 
Volterra et al., 2002; McKenna, 2007). The glutamate transport is accompanied by 
3 Na
+
 ions transfer for each glutamate molecule that cause remarkable sodium 
current in astrocytes involved in glutamate scavenging. Both maintenance of 
sodium homeostasis and glutamate conversion to glutamine are ATP-dependent 
processes and thereby stimulate glycolysis and lactate production in astrocytes. 
It seems that the role of astrocytes in activity-dependent neuro-glial metabolic 
coupling might be even more extensive and includes such aspects as regulation of 
vasoconstriction (Mulligan and MacVicar, 2004; Gordon et al., 2011) in response 
to Ca
2+
 transients in soma and endfeet as well rapid vasodilation mediated by local 
Ca
2+
 increase in astrocytic endfeet (Takano et al., 2006; Gordon et al., 2011). 
Astrocytic regulation of local blood flow and oxygenation level of brain tissue is 
not restricted to their influence on vessel diameter but also includes more 
generalized mechanisms of pH-dependent control of breathing via ATP signaling 
pathway (Gourine et al., 2010). Metabotropic glutamate receptor mediated Ca
2+
 
transients in astrocytes caused by stimulation of neuronal networks activity (Wang 
et al., 2006), might also be involved in fine tuning of astrocytic homeostasis and 
metabolism.  
It is also worth mentioning that astrocytes form an extensive metabolic network in 
the brain. Their coupling through connexin 43 and 30 channels allows trafficking 
of energetic substrates such as glucose (reviewed in Giaume et al., 1997) and ATP 
(Kang et al., 2008) between neighboring astrocytes and influences excitatory 
glutamatergic synaptic transmission within hippocampal neuronal networks 
(Rouach et al., 2008; Pannasch et al., 2011). Astrocytic K
+
 homeostasis is mediated 
by Na
+
,K
+
-ATPase activity in astrocytic plasma membrane and thus is dependent 
on ATP level and glucose utilization via glycolytic pathway in astrocytes. Ca
2+
 
dependent uptake of extracellular K
+
 by astrocytes can modulate neural network 
activity by transient local decrease of K
+
 ions leading to neuronal hyperpolarization 
and synaptic suppression (Wang et al., 2012). Thus, not only are Ca
2+
 and Na
+
 ions 
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connected with maintenance of neuro-glial metabolic coupling but K
+
 changes 
might also be involved in regulation of brain metabolism in an astrocyte-dependent 
manner. 
Astrocytes provide not just metabolic support for neuronal cells by lactate supply 
for TCA cycle but are involved in a metabolic crosstalk with neuronal cells that 
could even include such features as suppression of neuronal activity. They are also 
actively participating in regulation of cerebral blood flow, breathing control and 
can act as a metabolic network connected by gap junctions. Astro-neuronal 
metabolic coupling and the role of astrocytes in brain metabolism is strongly 
related to the fundamental role that astrocytes play as a component of multipartite 
synapses. 
2.2 Blood-brain barrier (BBB) formation and regulation by astrocytes 
The modern concept of BBB was summarized by Hugh Davson in 1976 (Davson, 
1976) and includes such features as barrier function per se, active transport and 
facilitated transport options across the barrier, leading role for endothelial cells in 
barrier formation and support, maintenance of brain homeostasis and ontogenetic 
developmental changes in BBB as well as significant role for astrocytes in BBB 
transport and homeostasis. To further develop this concept it is now an accepted 
fact that even though BBB is a relatively stable structure it continuously changes 
under different modulating factors among which astrocytes play not the least role 
(Abbott, 2005). 
BBB starts to form at embryonic developmental stages with the help of pericytes at 
the time when astrocytes have not yet appeared (Daneman et al., 2010). At later 
stages of BBB formation astrocytes participate in its establishment by direct 
contacts with pericytes and endothelial cells by their endfeet. Astrocytes are also 
supposed to play a role in BBB maturation and tight junctions formation by means 
of secretion of such angiogenic compounds such as Ang1, TGFβ, GDNF and FGF2 
(Quaegebeur et al., 2011). Particularly it was shown that factors derived from 
astrocytes can induce BBB-like phenotypes of endothelial cells and formation of 
tight junctions in vitro (Lee et al., 2003) suggesting an important role for astrocytes 
in BBB formation in vivo as well. 
Besides participation in BBB formation during ontogenesis, astrocytic components 
are involved in transport across the barrier. While small lipophilic molecules (less 
than 400 Da) can cross BBB by lipid-mediated diffusion (Pardridge, 2007), other 
compounds need to be transported actively or by mean of special channels and 
transporters. Strategic location of astrocytes between neurons and blood vessels 
makes them major players in glucose transport through GLUT1 transporters, water 
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through AQP4 channels (Abbott, 2006) and also ions, glutamate and other amino 
acids (Ohtsuki and Terasaki, 2007) across the barrier. For instance, spatial K
+
 
buffering by astrocytes provided by Kir4.1 channels located on perivascular 
astrocytic endfeet (Kofuji and Newman, 2004) as well as by other transporters such 
as Na
+
,K
+
-ATPase and NKCC1 (Abbott et al., 2006) were proposed to be one of 
the major mechanisms for maintenance of K
+
 homeostasis in the brain and for 
regulation of neuronal firing. 
By cryo-electron microscopy studies it was shown that astrocytic endfeet form 
orthogonal arrays of particles (OAPs) containing specialized sets of proteins 
located at contact sites with endothelial cells (Fallier-Becker et al., 2011; Nico and 
Ribatti, 2012). These polarized structural protein expressing micro domains are 
involved in maintenance of water and K
+
 homeostasis since they express aquaporin 
4 (AQP4) channels and Kir4.1 K
+
 channels segregated by agrin and α1-syntrophin 
(Abbott et al., 2006). Using dystrophin deficient mice it was shown that actin 
organization in astrocytic endfeet is crucial for AQP4 distribution and function 
(Nico et al., 2003) suggesting the role astrocytic actin cytoskeleton for clustering of 
OAPs and as a consequence its importance in regulating BBB properties. 
There is more and more evidence that most CNS pathologies involve some aspects 
of BBB disruption at least at some stages. Thus diabetes, alcohol, Ischemic 
conditions, HIV-1 infection are factors for BBB leakage (Zlokovic, 2008; Eugenin 
et al., 2011); inflammation processes can also cause opening of BBB (Huber et al., 
2001). Some of these pathological states involve astrocytes, thus astrocytic 
activation due to Alzheimer disease (AD) pathology and amyotrophic lateral 
sclerosis disease plays a role in BBB disruption in severe AD (Zlokovic, 2008). 
One of the possible mechanisms of astrocytic regulation of BBB permeability is 
based on ATP-mediated astrocytic and endothelium Ca
2+
 signaling. In this situation 
astrocytes act as a network connected by gap junctions and thus can propagate Ca
2+
 
and ATP mediated signals to neighboring cells. At the same time intracellular Ca
2+
 
changes in endothelial cells may act as a trigger for phosphorylation of 
cytoskeleton proteins and tight junctions opening (Abbott et al., 2006) increasing 
BBB permeability. 
Although BBB is mainly formed by endothelial cells and pericytes, astrocytes form 
numerous connections with both endothelial cells and pericytes and, as recently 
discovered, can regulate their functionality at least in terms of cerebral blood flow 
adjustment (Attwell et al., 2010). It is also unclear to what extent astrocytes can 
influence formation and integrity of tight junctions – one of most critical 
component of BBB. Although in vitro studies show astrocytic roles in almost every 
function of BBB (reviewed by Abbot et al., 2006), their role in BBB formation, 
maintenance and pathophysiology in vivo seems to be under studied. Focusing on 
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distal BBB components, like astrocytic endfeet, in the natural environment of the 
intact brain may shed light on novel therapeutic strategies based on selective BBB 
permeability, and open the way for new diagnostic approaches for CNS pathologies 
implicating unidirectional trans-BBB transport of diagnostic markers from CNS to 
the blood flow. 
2.3 Astrocytic function in maintenance and regulation of extracellular 
matrix (ECM) 
Regarding ECM we intend to take into account not just scaffold and cell-adhesion 
molecules but also soluble macromolecular factors derived from astrocytes, 
neurons and other cell types in the CNS. Roles of ECM can be divided in two main 
categories: mechanical that includes its implications in general and local diffusion 
properties of brain tissue (Sykova, 2004; Frischknecht et al., 2009; Zamecnik et al., 
2012) and as a consequence influencing synaptic as well as extrasynaptic 
transmission and cell migration in physical aspects; and biochemically active 
components of ECM affecting CNS properties via cell adhesion molecules, 
secretion of soluble proteins in extracellular space and protein-protein interactions 
in ECM (Dityatev and Schachner, 2003; Kochlamazashvili et al., 2010; Dityatev 
and Rusakov, 2011). Molecular scaffolds, cell adhesion, and soluble proteins that 
are synthetized and secreted by astrocytes play complex and important role in 
physiological (Ehlers, 2005; Faissner et al. 2010; Wiese et al., 2012; Hawkins et 
al., 2013) and pathological states of CNS (Pantazopoulos et al., 2010; Giordano et 
al., 2011; Beretta, 2012). 
Early in vitro co-culturing studies discovered the role of astrocytes in 
synaptogenesis and showed that astrocytes are able to produce some soluble factors 
that promote synaptogenesis even without direct astro-neuronal contacts (Pfrieger 
and Barres, 1997; Nägler et al., 2001; Ullian et al., 2001).  Later it was shown that 
astrocyte-derived cholesterol (Mauch et al., 2001) and thrombospondins 1 and 2 
stimulate formation of functional synapses at retinal ganglion cells (Christopherson 
et al., 2005). These findings suggested that astrocytes can be involved in 
synaptogenesis via secretion of ECM molecules. Additionally, it was demonstrated 
later that synaptogenic action of astroglia-derived thrombospondins is facilitated 
via gapapentin receptor, the α2δ1 auxiliary subunit of voltage gated Ca2+ channel in 
neurons (Eroglu et al., 2009). 
Recent studies have demonstrated that astrocytes in vitro secrete a number of 
proteins including procollagen, enolase, protein disulfide isomerase and Ser/Cys 
protease inhibitor (Schubert et al., 2009). It was also shown earlier that astrocytes 
can form a fibrillar collagen matrix when cultivated in vitro (Heck et al., 2003) and 
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in case of brain injury repair (Hirano et al., 2004). Taking into account that 
astrocyte-derived glioma cells also have epithelial-like phenotype (Lin et al., 
2002), it is tempting to speculate that activated astrocytes have some fibroblast 
features, particularly in their ability to form primary extracellular scaffolds 
containing collagen, laminin and fibronectin for cellular adhesion. 
In addition to general scaffold ECM proteins astrocytes are known to express 
different glycoproteins, such as chondroitin sulfate proteoglycans (CSPG) 
brevican, aggrecan, versican and phosphacan that are involved in CNS 
synaptogenesis regulation and can also influence Schwann cell migration (Pyka et 
al., 2011; Afshari et al., 2010). ECM glycoprotein tenascin C that plays a role in 
developing and mature CNS functionality including regulation of neuro-glial 
interactions in synapses (Theodosis et al., 2004; Faissner et al., 2010, Geissler et 
al., 2013), particularly it is able to regulate patterning genes in astrocytes during 
development of spinal cord (Karus et al., 2011) and modulate activity of membrane 
Ca
2+
 channels (Evers et al., 2002). Such glycoprotein as dystroglycan was shown to 
regulate general astrocytic endfeet organization and AQP4 distribution by linking 
ECM protein agrin with the cytoskeleton (Noell et al., 2011). In turn, heparan 
sulfate proteoglycan agrin, whose main function is related to astrocytic 
maintenance of BBB (reviewed by Abbott et al., 2006), is also known for its role in 
formation and maintenance of neuromuscular junctions by Schwann cells (Burden, 
1998). The story of astrocytic adhesion molecules would not been completed 
without mentioning ephrine-A3 ligand that is exposed on astrocytic surface and 
mediates signaling between neurons and astrocytes contributing to dendritic spines 
development (Murai et al., 2003). 
Integrin family proteins are also important for regulation of cell migration and 
proliferation mediated by astrocytes. Thus expression of α6β4 Integrin in astrocytes 
is related to their activation due to hypoxic conditions and act as a promoting factor 
for proliferation of endothelial cells (Li et al., 2010). At the same time another 
astrocyte-derived integrin αvβ8 is involved in sprouting of blood vessels during 
retinal development (Hirota et al., 2011). 
Astrocytes are known to express several types of matrix metalloproteinases (MMP) 
that are involved in cell migration by selective degradation of ECM molecules. The 
most studied MMP-9 whose activity is dependent on inflammation factors and on 
astrocyte activation (Hantamalala et al., 2012), has a pivotal role in a formation of 
glial scar after spinal cord injury (Hsu et al., 2008) and is involved in proteolysis of 
many ECM molecules that can promote neuronal death by degradation of vital 
laminin matrix or, on the other hand, can facilitate neurite outgrowth by degrading 
CSPG inhibiting components of surrounding ECM. It is known that such pro 
inflammatory agents that cause astrocyte activation as bradykinin can also induce 
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MMP-9 expression in astrocytes (Hsieh et al., 2008). Much less is known about 
MMP-2, but since it utilizes different distribution and trafficking compare to 
MMP-9 (Sbai et al., 2010) it is possible to assume that it might have different 
function or at least different regulation mechanism. A little aside from mentioned 
MMP-9 and MMP-2 there is another astrocyte-derived MMP-13 that can enhance 
permeability of brain endothelium under hypoxic conditions (Lu et al., 2009). 
Interestingly that astrocytes can regulate their MMPs on site by secreting specific 
inhibitors (Moore et al., 2011) providing local feed-back control of their activity. 
It is interesting to trace the role of astrocyte-derived ECM in different pathological 
states of the CNS as well even though some pathological aspects of ECM remain 
controversial. For instance, astrocytes are responsible for fibronectin production 
which can form aggregates on sites of multiple sclerosis lesions that proposed to be 
one of the factors that prevent remyelination and increase disease severity (Stoffels 
et al., 2013). Similarly different strategies for treatment consequences of CNS 
injuries are based on facilitation of neuronal process regrowth by prevention of 
glial scar formation and/or decreasing the level of CSPGs that thought to suppress 
neuronal regeneration (Gris et al., 2007; Cua et al., 2013). Effectiveness of such 
strategies is not univocal yet. 
Generally, active ECM deposition by astrocytes requires their activation by injury 
or internal inflammation process. Thus, pro inflammatory cytokine interleukin 1β is 
required for astrocyte activation followed by ECM production, regulation of cell 
adhesion and morphological changes (Summers et al., 2010). Interestingly, that 
some abnormalities in ECM, particularly related to reelin and CSPGs, were found 
in case of clearly psychiatric disorders, like schizophrenia, with no signs of severe 
brain damage and astrocyte activation (Pantazopoulos et al., 2010; Beretta, 2012). 
It is worth to mention in this context that some other CNS pathologies, like 
epilepsy, are related to changes in ECM and diffusion properties of the brain 
(Sykova, 2001) that is likely involve astrocytes. 
Despite there are comprehensive data about ECM molecules expressed by primary 
astrocytes in vitro (Dow and Wang, 1998; Heck et al., 2003; Schubert et al., 2009), 
unfortunately there is no detailed proteomic analysis for astrocytes in vivo under 
different conditions. Since astrocytic expression profile can change dramatically 
upon activation, we can only speculate what extracellular molecules derived from 
astrocytes are related specifically to pathological states where inflammation and 
astrocyte activation take place, how subset of proteins excreted by astrocytes 
changes over developmental stages and what characteristically for astrocytes and 
neurons in normal mature CNS. 
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2.4 Astrocytic coupling through gap junctions 
Being a unique feature of astroglia, coupling through gap junctions is of special 
interest. Connexins can act as adhesion molecule that provide formation and 
maintenance of astrocyte-astrocyte contacts as well as contacts between astrocytes 
and other cell types (Lin et al., 2002; Elias et al., 2007) or regulate functions of 
membrane receptors (Scemes and Giaume, 2006). Such connections through 
connexin 43 and 30 channels facilitate transmission of metabolic substrates and 
signaling molecules such as glucose, lactate and ATP (Tabernero et al., 2006; Kang 
et al., 2008; Rouach et al., 2008), ion permeability providing Ca
2+
, K
+
 and Na
+
 
waves (Harris, 2007; Rouach et al., 2008; Bernardinelli et al., 2004), and even the 
possibility for translational regulation by shRNA and miRNA transport (Valiunas 
et al, 2005; Katakowski et al., 2010). 
The first evidence for glial communication via gap junctions was obtained in 
sixties (Kuffler et al., 1966). There are at least 20 different connexin and 3 
pannexin genes that are expressed in mammals (Willecke et al., 2002; Bennett et 
al., 2012), but just two of them, connexins 43 and 30, are shown to be involved in 
formation of gap junctions connecting astrocytes (Wallraff et al., 2006; Rouach et 
al., 2008). Experiments with dyes and labeled molecules, such as Lucifer yellow 
and propidium, transferring between astrocytes showed that the connexin channel 
with a pore diameter of 1.0-1.5 nm is permeable for ions and small metabolites 
(with a cut-off of approximately 0.5 to 1.0 kDa) with almost no charge selectivity 
(Harris, 2001). 
Asking questions about the complexity of astrocytic network we should consider 
several facts and concepts. Thus, the exact limits (if they exist) for the number of 
individual astrocytes connected by the continuous gap junction network is not 
known, giving rise to the “pan glial syncytium” concept (Theis et al., 2005). The 
network might be even more tangled if reflexive gap junctions that connect 
different processes of the same cell (Giaume, 2010; Wolff et al., 1998), are taken 
into account. Diverse regulation of astrocytic network based on selectivity, gating 
properties, regulation and combinatorics of different gap junction channels also 
gave rise to the connexin “language” concept (Bruzzone and Giaume, 1999). 
Coupling through gap junctions mediates metabolic support functions performed 
by astrocytes via Ca
2+
 signaling. It was shown, for instance, that astrocytes can 
locally regulate vasoconstriction and vasodilation in a Ca
2+
 dependent manner 
(Koehler et al., 2009) and at the same time astrocytic coupling by gap junction is 
known to contribute to Ca
2+
 wave propagation (Hoogland et al., 2009). Thus, it is 
possible to conclude that astrocytic coupling via gap junctions can regulate 
direction (constriction or dilation), strength and determine the zone of blood flow 
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changes. Interestingly, Ca
2+
 waves could propagate both by connexins 
hemichannels-dependent mechanism, when Ca
2+
 increase generated de novo in 
each neighboring cell, utilizing ATP as a mediator (Kang et al., 2008; Hoogland et 
al., 2009), as well as by hemichannels-independent mechanism, when Ca
2+
 spreads 
directly through gap junctions in adherent astrocytes (Bennett et al., 2003). These 
two mechanisms presumably should differ by kinetics of Ca
2+
 signaling as well as 
by localization and distance for which Ca
2+
 signals are propagating throughout the 
astrocytic network. 
Often astrocytes are considered as separate cells that can individually influence 
neuronal functionality by different ways. Here we want to ask two major questions 
about involvement of astrocyte-to-astrocyte communication in regulation of 
neuronal network activity and vice versa. Does the astrocytic network regulate 
neuronal activity and does neuronal activity have an impact on the properties of the 
astrocytic network? 
There are several recent studies that address this question indirectly. For instance, 
ATP release (caused by Ca
2+
 mediated activation of astrocytes) from the glial 
network can promote distal synaptic suppression by adenosine (Serrano et al., 
2006). Also astrocytic network is involved as a functional unit in buffering K
+
 ions 
and thus, the modulation of general excitability of neurons (Wallraff et al., 2006). 
Although indirect evidence that astrocytic networks could modulate synaptic 
activity were known, a direct demonstration for this occurred only recently. It was 
shown that astrocytic coupling through connexins 43 and 30 is involved in 
regulation of neuronal excitability, release probability and insertion of new AMPA 
receptors in hippocampal synapses (Pannasch et al., 2011). These data suggest 
astrocytic coupling through gap junctions to be involved in such basic process as 
formation of new synapses and LTP induction. In addition there is interesting 
evidence for alignment between neuronal and astrocytic domain organizations in 
different brain areas (Houades et al., 2008; Roux et al., 2011). Thus, within 
somatosensory barrel cortex astrocytic coupling through gap junctions resembles 
the columnar organization of neurons, indeed, astrocytes within a single column 
have very strong coupling with much less intra columnar coupling (Houades et al., 
2008) suggesting the role of astrocytic communication in functional intracolumnar 
neuronal organization. 
One of the first studies that address directly this question was investigation of 
coupling between neuronal activity and increase in intra glial permeability in frogs 
(Marrero and Orkand, 1996). Later it was shown that neurons itself and neuronal 
activity upregulate connexin 43 expression in astrocytes and their coupling through 
gap junctions in mixed astrocyte-neuronal cultures (Rouach et al., 2000). The 
mechanism for tuning of astrocytic networks by neuronal activity is possibly 
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underlined by K
+
 dependent astrocyte depolarization (Enkvist and McCarthy, 
1994). 
In addition to maintenance of normal CNS homeostasis in some cases astrocytic 
coupling by gap junctions can disservice brain function and aggravate 
neuropathology. Thus, in case of HIV infection there is just small fraction of 
astrocytes of around of 8 % that are taking up the virus but coupling of infected 
astrocytes with healthy ones via gap junctions provides severe breach in BBB 
integrity (Eugenin et al., 2011). It was also shown recently that astrocytic coupling 
by connexin 43 but not by connexin 30 is involved in generation of neuropathic 
pain followed by spinal cord injury and consequent inflammatory reaction (Chen et 
al., 2012). In addition it has been reported that deletion of connexins 43 and 30 
leads to demyelination phenotype due to oligodendrocytes dysregulation (Lutz et 
al., 2009). All in all, reactive gliosis that is characterized by astrocytic 
morphological changes, increase in GFAP expression level and other signs of 
astrocytes activation, accompanying commonly different pathological states of the 
CNS and is mediated by signaling via gap junctions (Kuchibhotla et al., 2009; 
Koulakoff et al., 2012; Chen et al., 2012). 
Now it is accepted that gap junctional coupling of astrocytes is a subject for 
modulation by extra- and intracellular signals. Astrocytic syncytium not just 
summarizing properties of individual cells but acts as a new functional unit in the 
brain, influencing neuronal network properties (Giaume et al., 2010; Pannasch et 
al., 2011), and representing quantity to quality transition in some instances. 
2.5 Ion channels, transporter and receptors expressed in astrocytic 
plasma membrane 
Interaction with the environment as well as reaction to different stimuli coming 
from outside and inside the cell is mediated by receptors, channels and a variety of 
different transporters which facilitate information transfer between different cell 
types by means of signaling. Astrocytes that play an active role in communication 
with other cell type in the CNS, including neurons and microglia, express a range 
of transmembrane receptors, transporters and channels that provide permeability 
for different ions, transport of metabolic substrates, neurotransmitters and water. 
2.5.1. Glutamate transporters 
One of the major functions of astrocytes is glutamate uptake from a synaptic cleft 
that regulates spillover of glutamate, reduces the time for its action on postsynaptic 
receptors and maintains presynaptic pool of neurotransmitter by glutamate-
glutamine cycle (Fig. 2). Astrocytes express mainly two types of glutamate 
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Figure 2. Neuron-astrocyte signaling in the excitatory multipartite synapse. Glutamate-glutamine cycle shown in 
orange has several key steps: after release from a presynaptic terminal glutamate can activate postsynaptic 
receptors mGluRs at the astrocytic endfeet or extrasynaptic receptors. Glutamate scavenging kinetics by 
astrocytic GLUT as well as spatial positioning of PAPs determines both postsynaptic and astrocytic glutamate 
action. After been scavenged by astrocyte glutamate can be excreted by the reverse uptake or can be sent back 
to the presynaptic terminal in a form of glutamine. Glutamate metabolism due to its involvement in TCA cycle is 
tightly related to the metabolic state of the cell and maintenance of ion homeostasis via Na-K-ATPase and 
potassium channels. Signaling cascades involving cAMP and Ca2+ in the astrocyte can influence synaptic 
transmission in bidirectional fashion, causing presynaptic inhibition or activation via different types of 
metabotropic purinoreceptors or facilitate postsynaptic LTP via purines and D-serine release. Via releasing or 
scavenging glycine through the GlyT astrocytes are also involved in presynaptic glycine actions. 
 
transporters: excitatory amino acid transporter 1 (EAAT1) also called as glutamate-
aspartate transporter (GLAST) and EAAT2 that is also called glutamate transporter 
1 (GLT-1) (Danbolt et al., 1992; reviewed in Danbolt, 2001). Most studied and 
most abundant astrocytic glutamate transporter EAAT2 facilitates transport of 1 
glutamate molecule inside the cell accompanied with co-transfer of 3 Na
+
, 1 H
+
 and 
400 H2O molecules and pumping 1 K
+
 ion outside the cell. In this process Na
+
 ions 
are essential for substrate binding (Levy et al., 1998; MacAulay et al., 2001). Their 
activity could be chemically blocked in experiment with a range of selective 
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glutamate transporters antagonists such as dihydrokainik acid (DHK) (Johnston et 
al., 1979; Arriza et al., 1994) and DL-threo-beta-benzyloxyaspartate (TBOA).  
Glutamate transporters distributed unevenly in astrocytic plasma membrane; they 
mainly located on astrocytic processes that are in close contacts with synapses and 
much less abundant in somatic areas (Chaundhry et al., 1995) suggesting their 
primary role in uptake of synaptically released glutamate. In agreement with it is an 
observation that transgenic mice that lack EAAT2 expression demonstrated 
increased mortality and behavioral abnormalities (Tanaka et al., 1997), at the same 
time mice that overexpress EAAT2 were resistant to induction of epileptiform 
activity and had problems with LTP induction (Martinowich et al., 2001). 
In addition to uptake glutamate transporters can mediate release of glutamate via so 
called ”Reversed uptake” of glutamate (Rossi et al., 2000; Grewer et al., 2008), it 
could happened if cells loose energy source in case of ischemia or glucose 
deprivation (Nicholls and Attwell, 1990; Rossi et al., 2000) causing increase in 
spontaneous activity and excitotoxicity. It is worth to mention here that glutamate 
transporters are involved in coupling synaptic activity with astrocyte signaling 
(Volterra et al., 2002, pp. 46-56), thus glutamate to glutamine transformation cycle 
should be considered in a context of neuroglial metabolic coupling since glycolysis 
in astrocytes is dependent on glutamate uptake (see also part 2.1 for details).   
Such characteristic features of astrocytic glutamate transporters like their high 
density in perisynaptic regions of astrocyte, their high affinity to glutamate and the 
fact that much of the transporter current might be produced by low concentration of 
glutamate (Volterra et al., 2002, pp. 62-75) allow to propose that glutamate 
spillover and uptake regulated not chemically but spatially and are correlated rather 
with synaptic geometry than with transporters permeability (Freche et al., 2011; 
Freche et al., 2012). This idea is bringing us to a conception where astrocytes can 
actively participate in synaptic events by mean of their structural rearrangement 
and is the first link for involvement of astrocytic morphological plasticity in 
modulation of synaptic function. 
2.5.2. Connexin and pannexin hemichannels 
Along with specialized glutamate transporters astrocytes also express different 
channels facilitating transfer of small molecules and ions. Connexins that are 
known to form gap junctions between astrocytes are also presented as 
hemichannels in astrocytic membranes where they can mediate astrocytic 
activation by ATP and Ca
2+
 signaling (Bennett et al., 2003; Bennett et al., 2012; 
Chen et al., 2012). In addition to connexins there is also pannexin-1 hemichannels 
expressed in astrocytes. They are permeable for ATP, arachidonic acid derivatives, 
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are involved in Ca
2+
 waves propagation and might play a role vascular regulation 
(Bennett et al., 2012; Suadicani et al., 2012; MacVicar and Thompson, 2010). It 
was proposed also that hemichannels in astrocytes might mediate glutamate release 
(Ye et al., 2003) and thus play a role in coupling astrocytes with synaptic activity. 
2.5.3. Glutamate receptors  
Presence of functional ionotropic glutamate receptors in astrocytic plasma 
membrane is mysterious. Even though there were evidences for expression of 
ionotropic glutamate receptors mRNA and even functional NMDA and AMPA 
receptors in cortical and hippocampal astrocytes (Porter and McCarthy, 1996; 
Gallo and Ghiani, 2000; Schipke et al., 2001), their functionality remains 
controversial (reviewed by Volterra et al., 2002, pp .34-46). In opposite 
metabotropic glutamate receptors in astrocytes are well characterized and were 
shown to be involved in regulation of synaptic function (Perea and Araque, 2007; 
Panatier et al., 2011). Astrocytes were demonstrated to express mRNA for several 
metabotropic glutamate receptors subtypes; mGluR3 coupled with adenylate 
cyclase signaling pathway and mGluR5 that are connected to IP3 and Ca
2+
 
signaling cascade (Schools and Kimelberg, 1999). 
2.5.4. GABA receptors and transporters 
Besides excitatory glutamate sensing and release astrocytes are also exhibit 
sensitivity to inhibitory neurotransmitter GABA. It was reported that there is a high 
affinity GABA membrane transporter GAT-1 expressed in astrocytes (Minelli et 
al., 1995). On the other hand astrocytes can indirectly affect GABA-mediated 
synaptic transmission by influencing glutamate-glutamine cycle in presynaptic 
GABAergic terminal (Liang et al., 2006). There are also some evidences regarding 
metabotropic GABAB receptors which can trigger glutamate or ATP release from 
astrocytes (Kang et al., 1998; Serrano et al., 2006) and ionotropic GABAA 
receptors expression (Steinhäuser et al., 1994). Latter are known to be 
developmentally regulated and disappears in mature astroglia (reviewed by 
Volterra et al., 2002, in pp. 34-46). 
2.5.5. Channels and transporters involved in D-serine release from astrocytes 
Within a special interest astrocytic involvement in recently described D-serine 
actions (Panatier et al., 2006; Henneberger et al., 2010; Papouin et al., 2012). 
Astrocytes are proposed to express selective transporters for NMDA receptors co-
agonists such as D-serine transporter and glycine transporter 1 (GlyT1) (Papouin et 
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al., 2012). These transporters are thought to mediate glutamate stimulated release 
of D-serine and control of synaptic function through neuronal NMDA receptors co-
activation (Schell et al., 1995; Panatier et al., 2006). D-serine can also be secreted 
by astrocytes by less specific release mechanisms. It could be mediated by 
exocytotic release as well as by non-exocytotic release via P2X7 channels or 
volume regulated anion channels in case of astrocyte swelling (reviewed in 
Hamilton and Attwell, 2010). Despite it was clearly shown that D-serine released 
from astrocytes is a key regulator for synaptic plasticity and transmission (Yang et 
al., 2003; Panatier et al., 2006; Henneberger et al., 2010; Papouin et al., 2012), 
actual mechanism for D-serine release from astrocytes remains mostly elusive. 
2.5.6. Water and potassium channels 
Astrocytes intermediate exchange between neurons and blood vessels and thus are 
the main players in water homeostasis in the CNS. Their ability to regulate water 
balance is based on dense expression of aquaporin channels arrays. Aquaporins are 
the family of trans-membrane water channels. Whereas these channels are 
presented in different cell types, astrocytes express only AQP4 channel that at the 
same time is the most abundant water channel in the brain (reviewed by 
Papadopoulos and Verkman, 2013). AQP4 channels are mainly located on 
astrocytic endfeet surrounding blood capillaries as well on astrocytic processes that 
enwrap synaptic terminals (Nagelhus et al., 2004; Papadopoulos and Verkman, 
2013). Interestingly that AQP4 channels are coexpressed with Kir4.1 K
+
 channels 
both at astrocytic endfeet (Nagelhus et al., 2004; Abbott et al., 2006) and at 
perisynaptic astrocytic processes (Nagelhus et al., 2004) suggesting their synergetic 
role in maintenance of water and K
+
 homeostasis. Notably that astrocytic AQP4 
also plays a critical role in epilepsy (Binder et al., 2012) and during formation of 
traumatic brain edema (Nase et al., 2007). 
2.5.7. Purinoreceptors 
Purinergic signaling underlies many signaling events in astrocytes. Purine receptors 
family P2X1-7 mediating exchange of K
+
 to Ca
2+
 and N
+
 in a response to 
extracellular ATP, thus providing Ca
2+
 and Na
+
 influx to astrocytes. Astrocytes 
express at least two types of purinoreceptors P2X1 and P2X7 that differ by their 
affinity to agonist (reviewed by Illes et al., 2012) and are involved in different 
signaling cascades. As a part of ATP signaling system in astroglia it is worth to 
mention exocytotic mechanisms for ATP release in a response to intracellular Ca
2+
 
elevations (Bal-Price et al., 2002; Coco et al., 2003; Pangrsic et al., 2007; 
Pryazhnikov and Khiroug, 2008), suggesting exocytosis as one of the major 
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mechanism for bioactive substances release from astrocytes (reviewed in Hamilton 
and Attwell, 2010). 
2.5.8. Ephrin mediated reception 
In order to make the story about astrocytic receptors complete we should consider 
that signaling might be underlined not just by soluble factors that diffuse from one 
cell to another but also by integral membrane molecules that are working while 
cells have direct physical contacts. Commonly known ephrin-A3 ligands expressed 
on astrocytic surface can interact with their neuronal partners ephrin-A4 receptors 
located on dendrite. These interactions promote regulation of glutamate 
transporters in astrocytes and also involved in AMPA receptor endocytosis and 
degradation in dendritic spines as well as in Rac-mediated spine stabilization 
(reviewed in Murai and Pascuale, 2011). 
2.6 Chemical excitability and calcium signaling in astrocytes 
Astrocytes were long thought to be non-excitable cells when studied using 
electrophysiological tools applicable for neurons (reviewed in Verkhratsky et al., 
1998; Agulhon et al., 2008; Kirischuk et al., 2012). But as many other cell types 
they have signaling system underlying information transfer within the cell, 
astrocyte to astrocyte interactions as well as astrocyte interaction with other cell 
types like neurons, microglia and endothelial cells. Along with general signaling 
mechanisms astrocytes exhibit some unique signaling features that are originated 
from their gap junctional coupling and their intercalating position relative to 
neurons, synapses and blood vessels. 
Ca
2+
 is the most popular second messenger in different mammalian and non-
mammalian cell types (reviewed in Akerman, 1982; Gardner, 1989; Webb and 
Miller, 2003). It logically led to a general concept of Ca
2+
 excitability of astrocytes 
(Bowman and Kimelberg, 1984; Kettenmann et al., 1984; Jensen and Chiu, 1990; 
Verkhratsky and Kettenmann, 1996). Indeed, it was demonstrated that astrocytes 
can exhibit Ca
2+
 waves induced by glutamate application (Cornell-Bell et al., 1990, 
Charles et al., 1991) emerging the idea of glutamate dependent neuro-glial 
signaling and supporting the concept of astrocytic Ca
2+
 excitability. 
Even though astrocytes express channels that are permeable for Ca
2+
 ions, mainly 
changes in [Ca
2+
]i are mediated by Ca
2+
 mediated Ca
2+
 entry either from 
endoplasmic reticulum or mitochondria (reviewed by Verkhratsky et al., 1998). 
These astrocytic Ca
2+
 spikes are regulated by signaling cascades that involve G-
protein coupled receptors (GPCR) particularly mGluR5 (Panatier et al., 2011), 
protein kinase C phosphorylation and IP3 mediated signaling (reviewed by 
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Verkhratsky et al., 1998). It is worth to mention also that during brain maturation 
mGluR5 are replaced by mGluR3 that cause prevalence of adenylate cyclase 
mediated pathway and shifting mature astroglia signaling from developing one 
(Sun et al., 2013). On the other hand astroglial Ca
2+
 spikes mediate a range of 
different processes including exocytosis of ATP (Bal-Price et al., 2002; Pangrsic et 
al., 2007), D-serine (Panatier et al., 2006; Henneberger et al., 2010) and glutamate 
release (Liu et al., 2011). Unique astrocytic feature – their coupling through gap 
junctions and expression of hemichannels (Giaume, 2010; Bennett et al., 2003) 
provides additional options for Ca
2+
 signaling along ensembles of astroglial cells 
and can cause remarkable Ca
2+
 waves and synchronous astrocytic activity under 
physiological (Scemes and Giaume, 2006; Hoogland et al., 2009) and pathological 
conditions (Kuchibholta et al., 2009). 
It is interesting that if the modulation of Ca
2+
 signaling in astrocytes via GPCR 
activation caused by synaptic activity is doubtless (Dani et al., 1992; Porter and 
McCarthy, 1996; Wang et al., 2006; Perea and Araque, 2007; Gordon et al., 2009; 
Panatier et al., 2011; Min and Nevian, 2012) the feedback loop that includes 
modulation of synaptic function by astrocytic Ca
2+
 transients and transmitters 
release from astrocytes is under debate (Fiacco et al., 2007; Petravicz et al., 2008; 
Agulhon et al., 2010). There are several explanations for such ambiguous role of 
astrocytic Ca
2+
 in glia-neuronal communication. Most of them are relied on the 
idea of inadequate tools used for astrocytic stimulation (Agulhon et al., 2010; 
Nedergaard and Verkhratsky, 2012), possible involvement of another universal 
second messenger replacing Ca
2+
, for instance, Na
+
 ions (reviewed by Kirischuk et 
al., 2012; Bhattacharjee and Kaczmarek, 2005), or developmental shift in Ca
2+
 
signaling occurring in astrocytes (Sun et al., 2013). It is worth to remember at this 
point that spatial localization of the signal, direction and rate of its propagation as 
well as dose dependence should always be considered when artificial stimulation 
approaches are used.  For example ATP exocytosis from astrocytes triggered by 
Ca
2+
 transients has its own dose-dependent as well as temporal patterns 
(Pryazhnikov and Khiroug, 2008). Another elegant example where stimulus 
localization plays a critical role is provided by studies of local blood flow 
regulation by astrocytes. Exact location of Ca
2+
 elevations caused by local 
photolysis in soma or endfeet can cause opposite effects on blood vessels 
mediating either vasodilation or vasoconstriction (Takano et al., 2006; Gordon et 
al., 2011). 
If stimulus amplitude and timing could be easily controlled in standard 
experimental paradigms, directionality, rate and precise localization should be 
refined. Possibly novel genetically encodable tools that can be delivered to a subset 
of astrocytes and affect defined and well predicted properties of the cell 
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(Armbruster et al., 2007; Airan et al., 2009; Molotkov et al., 2013) combined with 
proper delivery and localization system will shed the light on the ambiguous role of 
astrocytes in modulation of synaptic function. 
Astrocyte excitability is accompanied by ion fluxes mediated by membrane 
channels in case of Na
+
 and Ca
2+
 or by internal stores mainly in case of Ca
2+
 and is 
coupled to neuronal activity. Moreover Na
+
 and Ca
2+
 mediated signaling might 
complement each other (Verkhratsky et al., 1998; Kirischuk et al., 2012). In fact 
Na
+
 homeostasis that is strongly dependent on Na
+
,K
+
-ATPase activity and glucose 
utilization (Bernardinelli et al., 2004) might connect Ca
2+
 signaling to metabolic 
status of astroglia thus coupling indirectly internal astrocytic Ca
2+
 signaling with 
glycolysis and neuronal activity. In addition to it the role of K
+
 ions also could be 
considered as possible indirect messengers for neuro-glial communication 
especially if astrocytic role in neuronal network activity regulation via K
+
 buffering 
(reviewed by Simard and Nedergaard, 2004) would be taken into account. 
Hypothesizing further we can propose that water homeostasis in astrocytes is a 
candidate for playing a significant role both in maintenance and regulation of 
general and local ion mediated signaling, coupling metabolic activity of astrocytes 
with Ca
2+
 transients, glutamate uptake and possibly exocytosis events. 
Despite application of advanced methodology the role astrocytic signaling inside 
the cell, among different astrocytes and also between astrocytes and neurons 
remains controversial with a prevalence of descriptive approaches to colligating 
ones. Diversity of methodological approaches might be one of the most critical 
factors that affect sensitive intracellular machinery. For instance, it was recently 
shown for awake mouse cortex that general anesthesia can disrupt Ca
2+
 signaling in 
astrocytes (Schummers et al., 2008; Thrane et al., 2012), but see also the work of 
Hirase and colleagues (Hirase et al., 2004) where astrocytic Ca
2+
 signaling was 
shown to be in a direct correlation with neuronal activity in anaesthetized rats. We 
can further suggest that signaling in primary astrocytic cell culture would be 
different from those in acute brain slice preparation that in turn would be different 
from whole brain in vivo situation. 
2.7 Modulation of synaptic transmission by astrocytes: the concept of 
multipartite synapse 
Complexity of chemical CNS synapse is often reduced to simple donor-acceptor 
model where presynaptic site releases neurotransmitter which is sensed by 
receptors on postsynaptic terminal. This view that pointing the synapse as one way 
neurotransmitter action site does not consider different important features of 
synapse such as geometry of synaptic cleft (Savtchenko and Rusakov, 2007), 
activation of extrasynaptic receptors (Kullmann and Asztely, 1998; Fellin and 
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Carmignoto, 2004), electrodiffusion of neurotransmitter caused by electrical fields 
generated near the synapse (Sylantyev et al., 2013), diffusion dynamics of 
neurotransmitter determined by ECM and surrounding cellular components 
(Sykova, 2004; Dityatev and Rusakov, 2011) and retrograde signaling that 
transform unidirectional synaptic transmission into crosstalk between pre and post 
synaptic terminals. This crosstalk which seemed to be a dialogue in a first 
approximation actually involves other active and passive participants besides 
neuronal components and generally synaptic events might be much more complex 
than proposed before. 
It was known for quite a long time already that glutamate uptake by glial glutamate 
transporters is involved in synaptic transmission and neuronal excitability (Tanaka 
et al., 1997; Bergles and Jahr, 1998; Oliet et al., 2001) moreover efficacy of 
neurotransmitter clearance appeared to be affected by structural interplay between 
neuronal and glial compartments of synapse (Oliet et al., 2001) that raises a 
question about the role of structure-functional relationship between glia and 
synaptic structures. Glutamate uptake function of astrocytes is accompanied with a 
well-known fact that glial cells can produce and release neuroactive substances 
(Martin, 1992) and particularly glutamate in Ca
2+
 dependent manner (Bezzi et al., 
2004; Marchaland et al., 2008; Santello and Volterra, 2009) and thus scale synaptic 
strength (Jourdain et al., 2007). It is also known that approximately 50% of 
hippocampal glutamate synapses are opposed to astrocytic processes and exhibit 
cooperative dynamics (Ventura and Harris, 1999; Witcher et al., 2007; Haber et al., 
2006). These morphological changes also may underlie synaptic development and 
spine stabilization (Nishida and Okabe, 2007; Haber et al., 2006; Murai et al., 
2003; Witcher et al., 2007). All mentioned above facts leaded to an idea of 
tripartite synapse (Araque et al., 1999; Perea et al., 2009) where astrocytes playing 
a role of active participants of synaptic events. Hypothesizing further it was 
proposed that ECM components represent a part of synaptic structure and involved 
in diffusion regulation, thus synapse representation could be upgraded to 
quadripartite structure (Sykova, 2004). Indeed, among non-neuronal cell types not 
just astroglia can actively participate in synapse functionality and structural 
changes. There are accumulating evidences that microglia could be an active 
synaptic partner as well (Bessis et al., 2007; Graeber, 2010; Tremblay and 
Majewska, 2011; Aguzzi et al., 2013; Kettenmann et al., 2013) allowing us to 
propose that the synapse represents a multipartite structure. 
Although the combination of ability of astrocytes to perform bidirectional control 
of synaptic strength (Navarrete and Araque, 2011) and their highly organized 
territories with no spatial overlap and coverage of different dendritic trees 
(Bushong et al., 2002; Volterra and Meldolesi, 2005; Halassa et al., 2007) together 
with evidences for activation of astrocytic signaling pathways in a response to 
sensory stimulation in vivo (Wang et al., 2006; Winship et al., 2007; Petzold et al., 
2008; Schummers et al., 2008; Nimmerjahn et al., 2009) allows to propose 
astrocytes as major CNS pacemakers. The astrocytic crosstalk with neurons is 
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controversial. Despite astroglia respond to neuronal activity by mean of metabolic 
and chemical activation, the influence of these events on synaptic events is under 
debate (Fiacco et al., 2007; Petravicz et al., 2008; Agulhon et al., 2010). In addition 
active glutamate conversion to glutamine in astrocytes by glutamine synthetase 
raises the question on sufficiency of glutamate concentration that is released by 
astrocytes (Barres, 2008). Even though astrocytes were shown to be able to 
generate Ca
2+
 responses fast enough (time to peak less than 500 ms) to intercalate 
with synaptic events (Marchaland et al., 2008; Santello et al., 2011; Di Castro et 
al., 2011; Winship et al., 2007). It is accompanied by the fact that vesicular 
glutamate transporters have not been detected in astrocytes with microarray 
expression studies (Lovatt et al., 2007; Cahoy et al., 2008) nor with microscopic 
investigations in cultured astrocytes and brain slices (Li et al., 2013) that puts a 
question mark on ability of astroglia to release glutamate in synaptic-like vesicles. 
We should consider there at least that neuro-glial communication differs across 
different brain areas and is a subject for developmental changes (Fiacco and 
McCarthy, 2006; Takata and Hirase, 2008; Nimmerjahn et al., 2009; Sun et al., 
2013). 
It is also need to be taken into account that astrocytic synaptic components are 
likely far away from being uniform; different parts of astrocyte can have different 
transporters and receptors profile they also can be on different distance from an 
active synaptic site, exhibit different morphological and functional responses. 
Actually if the release of neurotransmitter from presynaptic terminal is supposed to 
be all or nothing process its regulation by astroglia might be multimodal (Fig. 2). 
2.7.1. Presynaptic mechanisms of astrocyte action 
There are several ways how astroglial component of synapse can scale its activity 
via interaction with presynaptic neuronal terminal. These mechanisms involve 
astrocyte-neuron signaling through presynaptic glutamate GPCR and 
purinoreceptors. They are proposed to be involved in bidirectional control of 
synaptic strength both of basal synaptic transmition (Navarrete and Araque, 2011) 
(Fig. 2). 
2.7.1.1. Presynaptic action of purines released from astrocytes 
Astrocytes are known to release purines such as ATP and adenosine in a Ca
2+
 
dependent manner (Haydon and Carmignoto, 2006). At the same time both 
adenosine and ATP are supposed to be one of the major molecules providing glia 
to neurons signaling in synaptic and non-synaptic regions within peripheral (Fields 
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and Stevens, 2000; Housley et al., 2009) and central nervous system (Kato et al., 
2004; Haydon and Carmignoto, 2006; Rossi et al., 2007). 
Adenosine action via presynaptically located metabotropic A1 receptors or ATP 
action mediated by ionotropic P2X receptors decrease release probability at 
presynaptic terminal and depress synaptic transmission by damping Ca
2+
 events 
(Koizumi et al., 2003; Kato et al., 2004; Pascual et al., 2005; Serrano et al., 2006). 
Interestingly also that ATP binding by P2X receptors located to the somatic region 
of GABAergic interneurons in hippocampus can facilitate neurotransmitter release 
from synaptic terminal and thus suppress pyramidal neurons activity (Bowser and 
Khakh, 2004; Kato et al., 2004). This example demonstrates dualistic role for ATP 
action in a respect of receptors localization and context. 
The dualistic role for astrocyte derived adenosine was recently described as well 
(Panatier et al., 2011). Thus, it was shown that glutamate released from presynaptic 
terminal can activate astrocytic Ca
2+
 signaling via mGluR5 followed by exocytosis 
of ATP and adenosine that activate extrasynaptic A2A metabotropic adenosine 
receptors and increase release probability from the axonal terminal (Panatier et al., 
2011). This mechanism provides possibility for bidirectional control of synaptic 
efficacy by astrocyte derived purines. 
2.7.1.2. Modulation of synaptic events by presynaptic glutamate   
Glutamate was known as a major neurotransmitter in CNS (Moore, 1993). 
Prolonged action of glutamate caused by inefficient uptake by astrocytes underlies 
many pathological states (Rothstein et al., 1996; Tanaka et al., 1997; Bergles and 
Jahr, 1998). Astrocytes are contributing to glutamate mediated events occurred in a 
presynaptic terminal in two ways. First, being responsible for glutamate clearance 
from synaptic cleft and for control of glutamate spillover astrocytes are modulators 
of extrasynaptic mGluRs and NMDA receptors activation by synaptically derived 
glutamate (Haydon and Carmignoto, 2006; Rossi et al., 2007). This implication is 
thought to be highly sensitive to morphological changes of astrocytic perisynaptic 
terminals. Second possible mechanism utilizes active Ca
2+
 dependent glutamate 
release from astrocytes that leads to activation of presynaptic neuronal mGluRs 
followed by Ca
2+
 increase and promoting finally additional release of glutamate 
from a presynaptic neuronal terminal (Schwartz and Alford, 2000; Fiacco and 
McCarthy, 2004; Perea and Araque, 2007, Navarrete and Araque, 2010). This 
principle is controversial since it is not clear if astrocytes are able to produce 
glutamate containing vesicles (Lovatt et al., 2007; Cahoy et al., 2008; Li et al., 
2013) and if it is necessary for physiological synaptic functionality (Fiacco et al., 
2007; Petravicz et al., 2008; Agulhon et al., 2010). In addition, there are some 
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evidences that activation of astrocytic mGluRs may reduce glutamate release from 
astrocytes (Ye et al., 1999) and potentially can scale up astrocytic glutamate uptake 
(Vermeiren et al., 2005). Potentially this kind of events should lead to down 
regulation of synaptic activity and are not entirely consistent with other studies. 
2.7.2. Postsynaptic mechanisms of astrocyte action 
Postsynaptic terminal is a primary site for neurotransmitter action. Astrocytes can 
affect synaptic transmission by modulating different aspects of presynaptic events, 
for instance, controlling neurotransmitter availability for neuronal receptors and 
duration of its action or secreting neuroactive substances that trigger activation of 
signaling pathways in dendritic spines and even play a role of glutamate source 
(Parri et al., 2001) (Fig. 2). 
2.7.2.1. D-serine release from astrocytes 
D-serine can bind at the glycine modulatory site of the NMDA receptor and 
promote its opening in a presence of glutamate thus acting as a co-activator 
(Wolosker, 2006). It was proposed quite a while ago that D-serine derived from 
astrocytes can play a role of synaptic modulator and that its action is tightly linked 
with glutamate-induced activation of non-NMDA receptors type on astrocytic 
surface (Schell et al., 1995). Lately it was also shown that D-serine release from 
astrocytes can be involved in LTP induction in hippocampal synapses and thus its 
exocytosis is linked to glutamate release from a presynaptic terminal (Yang et al., 
2003). The conception that astrocytes can exclusively supply D-serine for NMDA 
co-activation during presynaptic stimulation and thus are a key component of LTP 
induction process was proofed in SON of hypothalamus (Panatier et al., 2006) and 
in classical hippocampal paradigm (Henneberger et al., 2010). Notably also that 
long term morphological changes of astrocytic synaptic component known for 
hypothalamus of lactating animals and Ca
2+
 clamping in astrocytes are also affect 
LTP induction by mean of availability of D-serine (Panatier et al., 2006, 
Henneberger et al., 2010; Fossat et al., 2012). There is also another link connecting 
D-serine release from astrocytic terminals with their structure-functional interplay 
with neuronal components of synapses. Indeed, it was shown recently that 
synthesis and exocytosis of D-serine from astrocytes is linked to Ephrin-mediated 
signaling that prerequisites direct contact between astrocytic and neuronal terminal 
(Zhuang et al., 2010). If D-serine deficit and lack of LTP induction in SON of 
lactating animals is caused by absence of direct astro-neuronal contact and Ephrin-
mediated signaling is still an open question. 
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Although astrocytes a thought to be an exclusive source of D-serine in major brain 
structures (Schell et al., 1995; Panatier et al., 2006) there are accumulating 
evidences that neurons can produce and release D-serine that on a par with 
astrocytic one can act as a mediator for postsynaptic NMDA receptors 
(Kartvelishvily et al., 2006; Rosenberg et al., 2013).    
2.7.2.2. Postsynaptic action of Glycine 
Glycine is one of amino acids neurotransmitters in the brain mostly known for its 
inhibitory action. Its binding to postsynaptic NMDARs is known to promote their 
internalization, suppress synaptic activity and promotes LTD (Nong et al., 2003). 
On a par with neurons astrocytes are potential source for glycine (Holopainen and 
Kontro, 1989) that is most prominently facilitated by reverse action of glycine 
transporters (Henneberger et al., 2013). On the other hand astrocytes are 
scavengers for glycine mediated by GlyT1 and GlyT2 as well (Fedele and Foster, 
1992; Verleysdonk et al., 1999; Zhang et al., 2008; Aroeira et al., 2013). 
Interestingly that glycine uptake by astrocytes as in many other cell types is 
mediated by protein kinase C signaling pathway (Morioka et al., 2008) and thus is 
a subject for Ca
2+
 dependent modulation. Recent studies also indicate that 
postsynaptic glycine action is mainly mediated by extrasynaptic NR2B containing 
NMDARs and that it may act synergistically with D-serine binding to synaptic 
NR2A containing NMDARs located at the synaptic site to promote LTD (Papouin 
et al., 2012). 
2.7.2.3. Postsynaptic action of astrocyte derived ATP 
Astrocyte derived ATP is known to modulate synaptic transmition by mean of 
postsynaptic action in addition to presynaptic one. Comparatively to diverse 
presynaptic purines action ATP interaction with postsynaptic P2X receptors 
increase synaptic strength likely by promoting insertion of novel AMPA receptors 
(Wang et al., 2004; Gordon et al., 2005) and underlie, for instance, astrocyte 
mediated norepinephrine action (Gordon et al., 2005). Both ATP release from 
astrocytes (Coco et al., 2003; Pangrsic et al., 2007) and ATP mediated changes in 
postsynaptic terminal (Wang et al., 2004; Gordon et al., 2005) are triggered by 
local intracellular Ca
2+
 mediated signaling. Contrarily to normal physiological 
conditions, under ischemia or hyper activation caused by epileptiform activity Na
+
 
entry via postsynaptic P2X channels may trigger Ca
2+
 release from mitochondrial 
stores, reactive oxygen species (ROS) production and cause activation of proteases 
leading to spine collapse and even apoptosis (Rossi et al., 2007). 
  
27 
 
2.7.2.4. Neurotransmitter and ion clearance by astrocytic transporters and 
regulation of spillover 
Involvement of astrocytes in glutamate-glutamine cycle that supplies neuronal 
demand in excitatory neurotransmitter and promote neuro-glial metabolic coupling 
also tightly linked to the ability of astrocytes to control glutamate clearance from a 
synaptic cleft via EAAT1, EAAT2 and maintain potassium homeostasis by K
+
 
syphoning through Kir4.1 channels and Na
+
,K
+
-ATPase. Glutamate clearance by 
astrocytes regulates duration of its action and also prevents or facilitates its 
extrasynaptic action. Indeed, glutamate spillover is an important factor involved in 
modulation of synaptic properties affecting both glutamatergic (Asztely et al., 
1997; Kullmann and Asztely, 1998) and GABAergic transmission (Semyanov and 
Kullmann, 2000). Similarly activation of extrasynaptic NR2B containing NMDA 
receptors by astroglia-derived glutamate may lead to neuronal cell depolarization 
by slow inward current and even trigger generation of action potentials (Angulo et 
al., 2004; Fellin et al., 2004; Perea and Araque, 2005; Navarrete and Araque, 
2008). In turn K
+
 syphoning by astrocytes decrease neuronal depolarization and 
decrease neuronal network excitability (Pannasch et al., 2011).   
Efficiency of glutamate uptake by astrocytes is thought to be dependent on 
structural interplay between neuronal and astroglial synaptic components and 
affected in supraoptic nucleus (SON) in hypothalamus of lactating animals (Oliet et 
al., 2001). Such morphological changes also involved in diffusion regulation (Piet 
et al., 2004) and might be the key to spillover and extrasynaptic transmission 
control (Rusakov, 2001; Scimemi et al., 2004; Papouin et al., 2012). 
3. Peripheral astrocytic process as a functional microdomain 
Astrocytes are known to have complex 3D morphology in vivo and in situ (Ogata 
and Kosaka, 2002; Bushong et al., 2002; Witcher et al., 2007; Hirrlinger et al., 
2004). Even though this complexity is reduced in vitro when individual astroglial 
cells are flattened on a culture dish bottom forming 2D structures astrocytes are 
able to form peripheral filopodia-like process containing actin (Molotkov et al., 
2013), actin related proteins such as ezrin and also mGluRs (Derouiche et al., 2001; 
Lavialle et al., 2011). Peripheral astrocytic processes (PAPs) are supposed to be 
main astroglial compartment responsible for neuro-glial interaction at synaptic 
terminals. Indeed, it was shown that PAPs are located in a close proximity with a 
majority of synapses. Thus, 56% of synapses in rat neocortex and 64 to 90%, 
depending on spine type, of synapses in rat hippocampus have glial enwrapping 
component nearby (Wolff, 1970; Witcher et al., 2007). 
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One astrocyte can contact with more than 100,000 synapses in rodent and up to 
1,000,000 synapses in the human brain (Oberheim et al., 2006). This huge 
integrating capacity is maintained by their highly ramified PAPs. At the same time 
astrocytes are known to occupy separate but partially overlapping territories (Ogata 
and Kosaka, 2002; Bushong et al., 2002; Derouiche et al., 2002; Livet et al., 2007). 
It is now accepted that each PAP can form separate functional microdomain with 
local Ca
2+
 signaling, localized receptors and channels (Grosche et al., 1999; 
Grosche et al., 2002; Reichenbach et al., 2010; Shigetomi et al., 2013(b)). 
Interestingly that astrocytic processes have a preference to postsynaptic terminals 
versus presynaptic ones that additionally regulated during brain maturation (Lehre 
and Rusakov, 2002; Nishida and Okabe, 2007). At the same time PAPs are known 
to participate in synapse stabilization via ephrine signaling with spines (Murai et 
al., 2003; Haber et al., 2006) and can be active regulators of synaptogenesis in 
developing brain (Nishida and Okabe, 2007). It is also known that, for instance, 
tonic oxytocin action in hypothalamic SON during lactation in rats causes PAPs 
retraction from neurons and synapses causing changes in functioning of those 
synapses and providing as well a unique model for studying long-term plasticity 
between neuronal and astroglial component (Theodosis and Poulain, 1993; Oliet et 
al., 2001). 
3.1 Ultrastructure of PAPs 
The term peripheral astrocytic processes was introduced by Derouiche and 
colleagues just a bit more than ten years ago in order to describe very thin 
filopodia-like protrusion in cultured astrocytes (Derouiche and Frotscher, 2001; 
Derouiche et al., 2002). These protrusions were too thin to be visualized with 
transmitted light microscopy and remained undescribed prior ezrin 
immunolabelling and fluorescent tracing of astrocytic plasma membranes. 
Alternative term such as peripheral glial processes (PGP) for these kinds of 
protrusions but meaning their appearance in close proximity to synapses in the 
brain in vivo was introduced by Reichenbach and colleagues in 2010 (Reichenbach 
et al., 2010). 
Thickness of astrocytic process can vary from 1 µm to 50-100 nm almost lacking 
the cytoplasm inside in this case; typically they are as narrow as 200-500 nm 
(Ventura and Harris, 1999; Witcher et al., 2007; Shigetomi et al., 2013). Although 
PAPs contain very small portion of astrocytic cytoplasm they represent a major 
fraction of cell surface of around 70-80% from total astrocytic membrane with 
extremely high surface to volume ratio that may reach 25 µm
-1
 (reviewed by 
Volterra et al., 2002, pp. 3-24; Grosche et al., 2002). Due to such high surface to 
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volume ratio visualization of PAPs could be effectively done using membrane 
bound fluorescent tracers in situ and in vivo (Benediktsson et al., 2005; Shigetomi 
et al., 2013(a); Molotkov et al.,in preparation (study III)). Interestingly there are 
evidences that the thinnest astrocytic process are also involved in neurotransmitter 
recycling and have all necessary machinery to participate in neurotransmitter 
exchange (Derouiche and Frotscher, 1991) at the same time it was shown using 
serial electron microscopy that thinnest parts of distal astrocytic process are mostly 
associated with synaptic structures (Witcher et al., 2007) suggesting their role in 
synaptic functioning. 
The shape of PAPs is not uniform they typically do not taper towards the end but 
have thicker regions interconnected by more narrow ones (Peters et al., 1991; 
Witcher et al., 2007). Based on observations made with serial electron microscopy 
and two-photon microscopy with membrane-targeted fluorescent tracers, it was 
also proposed recently that PAPs may form net-like rather than tree-like structures 
(Shigetomi et al., 2013(a); Molotkov et al., in preparation (study III)). Usually 
PAPs contain just little amount of organelles (reviewed by Reichenbach et al., 
2010) that differ them from dendrites but they might contain vesicles that thought 
to accumulate and release gliotransmitters such as D-serine, ATP and glutamate 
(Bezzi et al., 2004; Spacek and Harris, 2004; Jourdain et al., 2007; Witcher et al., 
2007; Kang et al., 2013). 
3.2 Receptors and transporters in PAPs 
Even though astrocytic component of synapse represented by PAP has relatively 
small volume it demonstrates expression for broad spectrum of different 
transporters and receptors that underlie crosstalk between neuronal and glial 
components in the tripartite synapse as well as promote local signaling for 
structural PAP remodeling. Thus, it is known that PAPs express high levels of 
glutamate transporters of both types EAAT1 and EAAT2 which facilitate 
glutamate uptake by astrocytes from a synaptic cleft (Chaudhry et al., 1995; Zhang 
et al., 2004) and can also participate in regulation of neuronal mGluRs or excrete 
glutamate by reverse uptake mechanism (reviewed by Grewer et al., 2008). These 
transporters may also underlie glutamate induced swelling of astrocytes (Koyama 
et al., 1991; O'Connor and Kimelberg, 1993). 
Besides glutamate uptake and secretion from and to synaptic terminals, PAPs are 
able to sense glutamate molecules via mGluRs (Lavialle et al., 2011; Panatier et al., 
2011) particularly by mGluR5 and mGluR3 which translate glutamate binding to 
Ca
2+
 elevations or activation of cAMP signaling pathway depending on the brain 
developmental stage (Sun et al., 2013). As an alternative mechanism for internal 
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store-independent Ca
2+
 signaling in PAPs the Ca
2+
 entry into astrocytes through 
TRPA1 channels was proposed (Shigetomi et al., 2013(b)). This mechanism does 
not require activation of IP3 signaling pathways and may operate in mGluRs 
independent way. 
Another group of channels expressed in PAPs is tightly linked to morphological 
changes of astroglial cells due to regulation of chloride, potassium and water 
homeostasis. Thus, chloride channels presented in PAPs were shown to mediate 
glial reshaping and swelling (Ransom and Sontheimer, 2001). On the other hand 
one of the theories for astroglial reshaping is based on water entry through AQP4 
which is enriched in PAPs where it is often colocalized with Kir4.1 potassium 
channels suggesting their mutual role in maintenance of water and K
+
 homeostasis 
in PAPs (Nagelhus et al., 2004; Holen, 2011). Another trans membrane protein 
presented on PAPs surface Ephrin-A3 ligand is involved in contact glia-neuronal 
interactions and was shown to regulate dendritic spine development and 
stabilization in a bidirectional fashion (Murai et al., 2003, Haber et al., 2006; 
Nishida and Okabe, 2007). Additionally Eprin-A3 and A4 interactions are involved 
in expression regulation of glutamate transporters in perisynaptically localized 
PAPs and thus can influence synaptic functional properties via modulation of 
glutamate uptake and spillover (Filosa et al., 2009). 
3.3 Morphological changes of PAPs: two different mechanisms proposed 
3.3.1. Aquaporin mediated morphological changes 
Water channel AQP4 is supposed to be potential regulator of cells shape (Nicchia 
et al., 2003; Nagelhus et al., 2004). Water uptake by astrocytes can cause swelling 
which, in turn, changes their contacting surface with neurons. Astrocytic swelling 
also affects activity of neuronal networks and is typical for several pathological 
states (Scharfman and Binder, 2013). Similarly rise of extracellular potassium 
might be one of keys for switching morphological changes of PAPs. Indeed, there 
is an evidence that increase of extracellular potassium ions can stimulate formation 
of new branches in cultured Muller cells (Reichelt et al., 1989). 
3.3.2. Actin-dependent morphological changes 
Actin cytoskeleton is the most common driver for different types of cellular 
motility including migration, rapid morphological changes of cell edge (Pollard 
and Borisy, 2003), lamellipodia and filopodia formation and extension (Faix and 
Rottner, 2006; Mattila and Lappalainen, 2008), exocytosis and endocytosis events 
(Muallem et al., 1995; Engqvist-Goldstein and Drubin, 2003). Generally actin 
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cytoskeleton is linking intracellular signaling to membrane dynamics and underlies 
as well receptor trafficking on the cell surface (Malinow and Malenka, 2002; 
Collingridge et al., 2004; Cingolani and Goda, 2008). Actin driving force is 
underlined by constant treadmilling cycle between monomeric actin pool and 
filamentous actin (F-actin) strands and can be regulated by many co-factors that 
acts as primers, exchangers and catalyzers for actin monomers (Pollard, 2003). 
The evidence that PAPs motility can be reduced by cytochalasin treatment (Haber 
et al., 2006) suggesting the active role of actin cytoskeleton remodeling for 
morphological plasticity of PAPs. This observation is also confirmed by the fact 
that morphological changes of PAPs are diminished by overexpression of 
dominant-negative form of small GTPase Rac that is known to be involved in 
cytoskeleton regulation (Nishida and Okabe, 2007). Besides functional evidences 
for actin cytoskeleton based motility of PAPs there are several structural supports 
for this idea. It is based on the evidence for localization of actin-related proteins 
such as ezrin (Derouiche and Frotscher, 2001) and α-adducin (Seidel et al., 1995) 
inside PAPs. Indeed, direct demonstration for the presence of F-actin inside 
astrocytic filopodia in culture was recently shown as well (Molotkov et al., 2013). 
PAPs outgrowth could be switched both by rise of [Ca
2+
]i (Molotkov et al., 2013) 
or by application of extracellular glutamate (Cornell-Bell et al., 1990; Hirrlinger et 
al., 2004). In both cases they demonstrate relatively high outgrowth rates of around 
1 µm·min
-1
 for brain slices with glutamate-induced outgrowth (Hirrlinger et al., 
2004) and approximately 3 µm·min
-1
 for cultured astrocytes stimulated by 
photolysis of caged Ca
2+
 (Molotkov et al., 2013). Most likely PAPs outgrowth is 
triggered by similar mechanisms as filopodia outgrowth in other cell types, for 
instance, fibroblasts or keratinocytes. The role of plasma membrane-to-
cytoskeleton linker Ezrin is within a special interest if focusing on reshaping of 
neuron glial connections. Regulated by phosphorylation/dephosphorylation it can 
potentially represent a key to rapid bidirectional activity-mediated morphological 
plasticity of PAPs (Gautreau et al., 2002; Lavialle et al., 2011). Other possible 
players are chloride channels that are known to have actin-dependent activity 
(Lascola et al., 1998; Ahmed et al., 2000) and bridging together “passive” 
astrocytic swelling and “active” actin-based astroglial motility. 
Finally it is interesting to address the question whether mGluR3 mediated 
activation of adenylate cyclase pathway can promote rapid morphological changes 
in PAPs similar to those that could be obtained by local Ca
2+
 uncaging or local 
glutamate application in rat neonatal astrocytes that supposed to mimic store-
operated Ca
2+
 entry mediated by mGluR5 receptors. 
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4. Methodological approaches to study neuro-glial interactions 
4.1 Hypothalamus as a classical model of PAPs retraction 
Morphology of the synapse is one of the critical aspects that underlies amount of 
postsynaptic receptors being activated and time course for neurotransmitter action 
as well as possible transactivation of neighboring synapses and extrasynaptic 
receptors (Freche et al., 2011; Allam et al., 2012). 
It was known a while ago that oxytocin can induce morphological changes in SON 
of hypothalamus in lactating rodents (Theodosis et al., 1986). These changes 
represent evidence for mature brain structural plasticity and was a unique case until 
recent studies of antidepressant-induced plasticity (Maya Vetencourt et al., 2008; 
Karpova et al., 2011). Lactation and increased oxytocin level induced long term 
retraction of astrocytic process from synapses and neuronal somata facilitating 
direct contact between neighboring neurons and blood vessels (Theodosis and 
Poulain, 1989; Theodosis and Poulain, 1993). This also affected glutamatergic 
synaptic transmission (Oliet et al., 2001; Panatier et al., 2006). Morphological 
changes in SON could also be driven by dehydration and changes in vasopressin 
level which also caused astrocyte retraction (Hatton, 1997; Theodosis et al., 2008). 
Interestingly, the model of astrocyte retraction in SON in a response to oxytocin 
works in vitro as well. Thus, bath application of oxytocin on brain slices containing 
SON caused similar rapid (within hours) and reversible morphological changes in 
astro-neuronal contacts as observed in vivo in lactating animals (Langle et al., 
2003). In addition dehydration and rehydration could be also used as a reverse 
switcher for GFAP level in astrocytes and may reversibly affect astrocytic 
morphology and coverage of neurons in SON (Hawrylak et al., 1998). If this model 
could be simplified for in vitro studies, by application of hyperosmotic solutions on 
an acute brain slice is questionable. 
4.2 Transgenic mouse models to study astrocytes 
Genetic manipulation in mice is a powerful tool to understand CNS physiology and 
pathology. It allows the study of particular gene function by their ablation or 
overexpression in a subset of cells in the brain using cell-type specific promoters. 
There are a number of different genetic strategies to manipulate and study 
astrocytes in a rodent brain (reviewed by Pfrieger and Slezak, 2012). Some of these 
approaches are based on available transgenic mice models. 
Glial fibrillary acidic protein (GFAP) is an intermediate filament component that is 
preferentially expressed in astrocytes and glial progenitors. Recombinant GFAP 
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promoter is the most studied and the most popular tool for transgene expression in 
astrocytes both in vitro and in vivo and is often used for generation of transgenic 
mouse lines. 
GFAP promoter as a tool for transgene expression in astroglial and neuronal cells 
has been known for more than 20 years (Mucke et al., 1991; Su et al., 2004). 
Besides endogenous promoter elements, its expression efficiency and specificity 
also depends on protein coding sequence for the gene of interest, its genomic and 
temporal context, methylation and acetylation status and genetic background of the 
animal (Su et al., 2004; Bai et al., 2013). Although, it is known that the 2.2 kb 
human GFAP (hGFAP 2.2 kb) promoter facilitates astrocyte-specific expression 
(Brenner et al., 1994); the same promoter variant was also used in several studies to 
direct expression to astrocytes, Muller cells and Schwann cells in the peripheral 
nervous system in transgenic mice (Zhuo et al., 1997; Nolte et al., 2001). 
Particularly intriguing is that when the 1.7 kb mouse GFAP promoter is delivered 
to neonatal rat brain in the form of a bacterial plasmid by in vivo electroporation, it 
has an expression preference for neurons rather than astrocytes (Molotkov et al., 
2011). 
Novel variants of engineered transgenic mice provide more flexibility in exogenous 
gene expression in astrocytes and allow combining, for instance, specificity and 
efficiency of a well characterized promoter with flexibility of viral gene delivery 
approaches. Thus, transgenic mice expressing Cre recombinase under the control of 
hGFAP 2.2 kb facilitates homologous recombination and stable expression of the 
gene of interest in astrocytes (Zhuo et al., 2001; Hirrlinger et al., 2006). This 
system could have additional temporal control facilitated by inducible Cre 
(Hirrlinger et al., 2006). However, it was shown that some neurons also express 
Cre in this model (Zhuo et al., 2001), thus additional specificity filtering by 
addressed gene delivery done by viral vector has a good potential in this model, if 
an absolute specificity to astroglia is needed. 
Time-lapse microscopy on thin structures such as PAPs was always a challenge 
due to poor signal to noise ratio and a size that is sometimes less than the 
diffraction limit for light microscopy. However, at least two transgenic mouse 
models expressing cytoplasmic EGFP were shown to be effective for studying 
PAPs dynamics. The first one is based on the mouse 2.6 kb GFAP promoter 
(Suzuki et al., 2003), and another one utilizes the 2.2 kb hGFAP promoter to direct 
EGFP expression to astroglia (Hirrlinger et al., 2004). Both models demonstrated 
that PAPs dynamics could be studied with cytoplasmic fluorescent reporters, and 
that the expression level of GFAP promoter is sufficient to get a good signal to 
noise level. Nevertheless both the resolution and expression efficiency in these 
studies were subject to future improvement. 
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The promoter is not a uniform sequence, it might contain parts responsible for 
transcription itself (core promoter), as well as parts that can modulate promoter 
efficiency in a bidirectional fashion. Thus, a large 2.2 kb segment of human GFAP 
promoter contains not only the elements that enhance transcription of a 
downstream gene, but also elements that can decrease promoter efficiency. 
Interestingly, the minimal 447 bp long gfa28 promoter directs expression only in a 
subset of astroglia and its expression efficiency is not altered by injury as classical 
2.2 kb hGFAP promoter; moreover, it was shown that its restricted activity is 
dependent on chromatin remodeling by histone deacetylation during development 
(Lee et al., 2006). These finding led to an idea that some enhancer elements of 
GFAP promoter can increase transgene expression without affecting astrocyte 
specificity (Lee et al., 2006) and to the creation of improved astrocyte-specific 
promoter. The novel gfaABC1D promoter, which is only 681 bp in length, and 
which was obtained from the 2.2 hGFAP promoter, contains all necessary elements 
for strong and astrocyte-specific expression and lacks all the elements that suppress 
expression. It demonstrated higher efficiency and specificity when it was used for 
creation of transgenic mouse strain (Lee et al., 2008). 
Another prospective strategy to improve expression specificity in transgenic mice 
utilizes the so called “Split-Cre” system that overcomes expression specificity 
problems, since simultaneous expression from two cell-type specific promoters is 
needed to activate recombination (Hirrlinger et al., 2009). This model has also 
demonstrated its usefulness for studying cell differentiation in vivo (Hirrlinger et 
al., 2009). 
4.3 Acute brain slices and organotypic cultures to study neuro-glial 
interactions 
The brain is a complex organ where structure and intracellular interactions are of 
the same importance as its individual components. Brain slices provide an easy-to-
use and reliable alternative for in vivo approaches to study properties of individual 
cells as well as interactions between different cell types. This feature is the most 
valuable when such property of the brain as connectivity is investigated.  
There are many examples of the use of acute brain slices obtained from different 
brain areas for studying neuro-glial and interglial interactions which demonstrate 
the potential of this model (Hirrlinger et al., 2004; Panatier et al., 2006; Perea and 
Araque, 2008; Rouach et al., 2008; Henneberger et al., 2010; Panatier et al., 2011).  
Ease of accessibility to the slice has made it possible to perform advanced 
electrophysiological recordings and dye infusion via patch pipette (Perea and 
Araque, 2008; Rouach et al., 2008; Henneberger et al., 2010; Panatier et al., 2011; 
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Pannasch et al., 2012). Combination of slicing procedure with the use of transgenic 
mouse models or application of viral vectors expressing fluorescent reporters 
allows performing high resolution imaging of entire astrocytes and their peripheral 
processes (Hirrlinger et al., 2004; Shigetomi et al., 2013(a)). Despite their many 
advantages, acute brain slices were shown to be different when compared to an 
intact brain. Thus, it was shown that in acute hippocampal slices dendrites form 
additional synapses that are not characteristic for hippocampus in situ (Kirov et al., 
1999). Another issue that should be addressed is the post-slicing recovery 
conditions and timing that significantly affect the morphology of glia and neurons 
in acute brain slices (Fiala et al., 2003; Kirov et al., 2004). 
As an alternative to acute brain slices, the procedure for preparation of organotypic 
brain cultures has been developed (reviewed by Gähwiler et al., 1997; Gähwiler et 
al., 2001). Originally invented as a roller-tube culturing method (Gähwiler, 1981; 
Gähwiler, 1984), it results in obtaining a 1-2 cell layer of brain tissue that 
resembles the entire architecture of the brain region from which it was dissected 
(Gähwiler et al., 1997). The method was further simplified and improved to 
stationary interphase culturing method using porous membrane as a substrate for 
the slice (Stoppini et al., 1991). Cultivation results in 1-4 cell layer thick culture in 
which organotypic morphological and functional organization is relatively well 
preserved. The well-defined procedures for preparation of such slice cultures (De 
Simoni et al., 2006), their applicability for long term imaging experiments (up to 6-
8 weeks) (Gogolla et al., 2006), good optical transparency and their convenience 
for different transfection procedures (Wirth and Wahle, 2003) combined with 
preserved cell morphology and connectivity, have made organotypic brain slices a 
popular tool to study astrocytic morphological changes and neuro-glial interactions 
(Benediktsson et al., 2005; Haber et al., 2006; Nishida and Okabe, 2007; 
Bernardinelli et al., 2011). 
4.4 In vivo methods to probe astrocytic morphological and functional 
changes 
4.4.1. Two-photon microscopy on living mouse brain 
Since its invention more than twenty years ago (Denk et al., 1990), two-photon 
excitation microscopy (TPEM) became a powerful tool for understanding 
processes in the brain with cellular and subcellular resolution due to its good 
penetration depth and high resolution. TPEM is applicable for functional imaging 
in individual neuronal and glial cells as well as in their distal processes, using 
synthetic or genetically encoded Ca
2+
 indicators enabling longitudinal studies of 
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development of brain pathological states and tracing morphological changes 
underlying memory (reviewed by Bacskai et al., 2002; Helmchen and Denk, 2005; 
Svoboda and Yasuda, 2006). Recently, it became also possible to perform TPEM 
on awake rodents involved in virtual navigation tasks (Dombeck et al., 2007; 
Dombeck et al., 2010).Additionally, two-photon microscope is not just a tool for 
observation but also a tool for manipulation. Thus, it is possible to produce a local 
stroke by thrombotizing a single penetration arteriole (Nishimura et al., 2006; Shih 
et al., 2013), to use a laser beam for photolysis of caged compounds (Noguchi et 
al., 2011), photoactivate fluorescent markers (Piatkevich et al., 2013), optogenetic 
manipulation (Figueiredo et al., 2011; Prakash et al., 2012) or for direct activation 
of astrocytes (Choi et al., 2011). 
In vivo microscopy on the brain requires an optically transparent skull. Currently, 
there are two distinct techniques available to prepare cranial optical window with 
their advances and limitations (Xu et al., 2007). The craniotomy method, in which 
a part of the bone is removed and replaced with glass (Holtmaat et al., 2009); has 
an advantage of higher transparency and as a consequence better penetration depth 
for light; on the other hand, post-surgical recovery period for such preparation is 
around 2-3 weeks. In addition, the glass transplant does not allow injecting any 
substances under the cranial window during experiment. As an alternative for 
craniotomy, there is a method for thinned polished skull preparation (Xu et al., 
2007; Drew et al., 2010). This preparation induces much less inflammatory 
changes in the brain since it is almost non-invasive, but lacks perfect optical 
transparency and long-term stability featured by craniotomy. 
Recent development of in vivo microscopic imaging techniques provides a good 
opportunity to manipulate and to observe neuro-glial interactions in the intact 
rodent brain and to study rapid changes in glial morphology as well as long term 
neuro-glial plasticity. 
4.4.1.1. Probes and dyes to label astroglia in vivo for TPEM 
In vivo patching techniques for unlabeled neuronal cells (Kitamura et al., 2008; 
Witte et al., 2011) are difficult to apply for astrocytes due to their small soma 
dimensions. This obstacle makes it problematic to load individual astroglial cells 
with tracers in vivo. The dye that can overcome these limitation should have 
intrinsic tropism to astroglial cells, thus being applied topically to the brain surface 
or injected to the brain parenchyma should and be able to enter specifically 
astrocytes. A synthetic water-soluble dye sulforodamine 101 (SR101) was shown 
to solve the problem of astrocyte-specific labeling via bulk loading in rodent 
neocortex in vivo and trace astrocytic morphology when used in combination with 
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two-photon excitation microscopy (Nimmerjahn et al., 2004). Most likely the dye 
enters cells via active uptake (Schnell et al., 2012). Later this dye was shown to be 
effective also for in vivo labeling of Bergman glia cells in the cerebellum of freely 
moving mice (Nimmerjahn et al., 2009) and for astrocyte loading in hippocampus 
in acute brain slices (Kafitz et al., 2008). Despite SR101 benefits, it has also some 
limitations (Nimmerjahn and Helmchen, 2012). Particularly it was shown that, 
when applied to hippocampus, SR101 can enhances activation of NMDARs, 
trigger spontaneous neuronal firing and may cause in vivo epileptic seizures (Kang 
et al., 2010) and, thus may interfere with results obtained from tracing astrocytic 
morphology. It was also shown that SR101 uptake to astrocytes changes during 
developmental stages (Kafitz et al., 2008). 
In comparison to neurons, astrocytes are known to lack electrical activity but they 
can interact with each other by Ca
2+
 waves (van den Pol et al., 1992). Intracellular 
Ca
2+
 is also a key player for astro-neuronal signaling (Fiacco and McCarthy, 2004) 
and for induction of morphological changes in astrocytes (Molotkov et al., 2013). 
Monitoring Ca
2+
 events in vivo in astrocytes and their processes constitutes a 
special interest. Two prospective strategies are currently available for highly 
localized Ca
2+
 imaging. The first one utilizes newly developed fast and sensitive 
Ca
2+
 sensor GCaMP6 for detection of highly compartmentalized neuronal Ca
2+
 
domains in vivo (Chen et al., 2013). Another approach that was tested on acute 
brain slices is based on targeting GCaMP sensor to astrocytic plasma membrane 
which improves signal to noise ratio and improves resolution when Ca
2+
 signals in 
PAPs are monitored (Shigetomi et al., 2013(a)). Combination of these two 
approaches may lead to a creation of Ca
2+
 sensor optimized for in vivo TPEM on 
PAPs.  
4.4.1.2. In vivo microscopy on anaesthetized animals 
An intact entire brain provides much more appropriate preparation for studying its 
function than organotypic cultures or acute brain slices. Moreover, some aspects of 
brain functionality cannot be studied in those simplified preparations. These 
aspects include cerebral blood flow and brain pH regulation by glial cells (Attwell 
et al., 2010; Gourine et al., 2010), long term structural changes related to 
experience (Hofer et al., 2009), network activity (Svoboda et al., 1997; 
Kuchibhotla et al., 2009) and pathology development (Bacskai et al., 2002). All 
these questions could be addressed in anaesthetized animals. To make complex 
things simpler, it was shown recently that use of conventional laser scanning 
microscope for in vivo imaging is also possible (Perez-Alvarez et al., 2013). We 
can conclude that the main advantage of in vivo microscopy performed on 
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anaesthetized animals is a combination of its relatively high relevance with relative 
simplicity, although its results should be interpreted with caution since the brain is 
the main site of action for all general anesthetics. 
4.4.1.3. In vivo microscopy on awake animals 
General anesthetics cause disruption of Ca
2+
 signaling in astrocytes and may have a 
strong impact on data obtained on anesthetized animals (Schummers et al., 2008; 
Thrane et al., 2012). Moreover some experimental paradigm such as different 
cognitive and behavioral tasks or coupling between cerebellar neuronal activity and 
Bergman glia Ca
2+
 signaling during exploratory behavior (Nimmerjahn et al., 2009) 
is impossible to perform on unconscious animals.  
The first approach for imaging in freely moving animals came from the idea of 
miniaturized microscopic device that can be mounted on animal’s head without 
restricting its movements (Helmchen et al., 2001; Flusberg et al., 2008; Ghosh et 
al., 2011). These microscopes can be placed in cortical as well as in hippocampal 
regions of the brain and allow imaging of individual cells, blood vessels and 
measure a blood flow dynamics. The main limitation for these systems is their 
narrow field of view, stationary positioning, high level of customization and 
relatively low numerical aperture restricted by limited optics dimensions. 
As an alternative, commercially available upright microscopes can be used in 
combination with systems that compensates for an animal’s movements. The first 
prototype of a spherical treadmill was shown to be effective for microscopy on 
awake mice (Dombeck et al., 2007) as well as for complex behavioral paradigms 
utilizing virtual reality (Harvey et al., 2009). The main advantages for this strategy 
are the use of commercially available stock optics, higher resolution and better 
signal to noise ratio due to the possibility to use high numerical aperture objectives. 
On the other hand this approach is difficult to apply for hippocampus or deeper 
brain regions without affecting sensitivity. 
Another obstacle that concerns both approaches are artifacts caused by animal 
movements that always appear when in vivo microscopy on awake animal is 
performed. Indeed, there are several software modules available that help to 
overcome this problem. 
The possibility to perform automated short term repetitive imaging sessions was 
reported recently on behaving rats (Scott et al., 2013). Short image acquisition time 
(up to 8 seconds), firm attachment of the head plate to microscope stage for the 
moment of image acquisition and animal comfort can provide better image quality 
than in long term sessions when the animal is forced by unnatural stimuli to be 
head restrained. 
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In vivo microscopy on non-anaesthetized animals is the most natural microscopic 
approach that allows combining micrometer spatial resolution, millisecond 
temporal resolution and lack of artifacts caused by general anesthetics. The set of 
these methodological applications might help us to understand how commonly 
used anesthetics affect an entire brain and each of its components, and what is 
happening in the brain during behavior. 
4.5  Gene delivery to astrocytes 
Even though transgenic animals provide a wide range of ready-to-use solutions or 
can be generated for particular purposes, they lack flexibility – the characteristic 
feature of acute gene delivery approaches. For instance, it is very difficult to create 
a transgenic mouse line that will express different genes in two or more similar 
brain regions. In contrast, such an option is feasible with focal multiple point gene 
delivery by means of viral vectors. Another issue we will address here is astroglia 
as a prospective target for gene therapy approaches in clinical cases. In this part we 
will discuss some methodological approaches allowing transient or stable transgene 
expression in astrocytes in vitro and in vivo, especially focusing on their expression 
efficiency and specificity.  
4.5.1. Specificity and efficiency of gene delivery to astrocytes 
Both specificity and efficiency of expression are always an issue for in vivo gene 
delivery, since there are many different cell types in the brain that sometimes are 
difficult to distinguish and there are many chemical and mechanical barriers that 
are difficult to overcome. For in vitro applications, when the dissociated cell 
culture primarily contains cells of interest or cells which can be distinguished 
easily by their morphology or other linage markers, the efficiency of transfection 
maybe the major problem. Cell-type specificity and expression efficiency in vitro 
and in vivo is determined by factors which only partially overlap. Thus, use of 
astrocyte specific promoters such as hGFAP, gfaABC1D (Lee et al., 2006; Lee et 
al., 2008) or ubiquitous cytomegalovirus (CMV) promoter (Thomsen et al., 1984; 
Jeang et al., 1984) in combination with standard transfection protocols is usually 
the best and simplest choice for dissociated astrocytic cultures. Both CMV and 
enhanced versions of hGFAP promoter, such as gfaABC1D, result in relatively 
high expression levels in astrocytes in vitro.  
The situation is changed if there is a need to transfect astrocytes in organotypic 
cultures that contain other cell types in addition to astrocytes, as well as 
extracellular matrix proteins. Moreover, presence of several cellular layers may 
prevent gene delivery to the lower parts of the slice. These obstacles can be 
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effectively overcome with ballistic gene delivery using different types of available 
gene guns (O’Brien et al., 2001; Benediktsson et al., 2005; Shefi et al., 2006) or by 
using electroporation combined with electro diffusion (Murphy and Messer, 2000; 
Kawabata et al., 2004).  
The most demanding case appears to be the in vivo applications when specificity of 
promoters is not same as in the in vitro situation and may be determined by several 
factors including the age of the animal, particular brain region, source of 
exogenous DNA encoding the transgene and promoter. Such factors as microglial 
and astroglial activation caused by application of exogenous biomaterial should be 
also considered. Side by side with efficient viral vector strategies (reviewed by 
Merienne et al., 2013) there are non-viral alternatives based on postnatal (Barnabe-
Heider et al., 2008; Molotkov et al., 2010; De la Rossa et al., 2013) and prenatal in 
utero electroporation (Saito, 2006; Dixit et al., 2011). In the case of viral vector 
mediated expression the specificity and efficiency is determined by nature of the 
virus and the promoter; while in the case of electroporation it is determined by the 
promoter and to a lesser degree by the source of DNA, its methylation and 
conformation. Further we will go through some approaches that were shown to be 
more or less effective for targeting transgene expression to astrocytes. 
4.5.2. Gene-gun mediated gene delivery (biolistics) 
The principle of the gene-gun or ballistic mediated delivery system is relatively 
simple. It utilizes gas pressure to accelerate small (around 1 µm in diameter), heavy 
(made of gold or tungsten), dispersed particles – “bullets”. Accelerated particles 
work as carriers for different molecules that can be attached to their surface such as 
DNA, proteins or small molecules like dyes. The relatively high speed and density 
of particles allow them to penetrate biological tissues to a depth of up to 100 
microns, depending on preparation type. This penetration depth is ideal for 
organotypic brain slices, for instance, in which the normal thickness rarely exceeds 
100 microns (Biewenga et al., 1997; O’Brien and Lummis, 2004).  
There are two approaches available for particle acceleration. In the classical gene 
gun that is used for gene delivery and immunization both accelerated particles and 
the accelerating gas stream reach the transducing tissue (reviewed by Johnston and 
Tang 1994). The blast wave of accelerated gas may cause tissue damage, thus 
several approaches were developed to protect biological sample from outflowing 
compressed gas (O’Brien et al., 2001). Alternative method solving this problem 
was developed by Shefi and colleagues and is based on the idea that the bullets do 
not need accelerating gas flow after they left the accelerating channel of the gene 
gun. Their system is designed in way that the exhausting gas is scavenged before it 
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reaches the tissue (Shefi et al., 2006). This method minimizes tissue damage 
caused by gas pressure and improves penetration depth for particles by decreasing 
the distance between the gene gun accelerating channel and tissue sample. 
4.5.3. In vivo electroporation 
Electroporation is based on a principle that a charged DNA molecule in a form of 
highly compacted circular plasmid can migrate fast in electrical field created by 
application of rectangular electrical pulses and cross cellular plasma membrane. 
The fate of the DNA that entered the cell is unclear; it is also unclear how plasmid 
is able to cross nuclear envelope to be transcribed (Nishikawa and Huang, 2001; 
Wells, 2010). It was shown, indeed, that compounds improving the DNA migration 
into the nucleus also improve efficiency of its expression in non-dividing cell types 
after in vivo electroporation (De la Rossa et al., 2013). 
There are two main subtypes of electroporation technique: the one that is done 
prenatally on rodent uterus on prenatal days 14 – 16 targets efficiently dividing and 
migrating neuronal precursors and was not reported to target astroglial cells. The 
plasmid solution in this case is injected into the embryo brain ventricles and 
targeting of brain region is determined by positioning of electrodes (Saito, 2006; 
Dixit et al., 2011). Postnatal electroporation that can be done on the first postnatal 
week or even on adult animals (Boutin et al., 2008; Molotkov et al., 2010; 
Barnabe-Heider et al., 2008; De la Rossa et al., 2013) allows delivering the DNA to 
the site of interest by mean of stereotaxic injection and, thus facilitates targeting 
non-migrating cell types such as cortical astrocytes. 
Choosing the correct promoter is a critical step for successful in vivo 
electroporation both for in utero and postnatal variants. Thus, CMV 
enhancer/chicken β actin (CAG) promoter was shown to be the most effective to 
target variety of cell types and cause high and stable expression for several weeks 
(Matsuda and Cepko, 2007). Expression in astrocytes and radial glia in neonatal rat 
cortex can be also targeted by CAG promoter (Molotkov et al., 2010). On the other 
hand, mouse GFAP 1.7 kb promoter facilitates expression in neuronal cells of 
neonatal rat cortex when delivered by postnatal electroporation (Molotkov et al., 
2011). Some common promoters such as CMV do not cause efficient gene 
expression when delivered by in utero or postnatal electroporation for unknown 
reason. The plasmid quality and purification method are very critical for the 
efficiency of transgene expression as well for minimizing inflammation response in 
the brain that can be caused by bacterial polysaccharides that are common 
contaminants for bacteria-derived plasmid DNA. Thus, individual testing for each 
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genetic construct is recommended to be done in vivo in order to determine its 
expression efficiency and specificity. 
4.5.4. Viral gene delivery methods to get astrocyte specificity in vivo 
Specificity or tropism of the virus is determined by interaction between the virus 
envelope or capsid proteins with receptors on cell surface. Additionally, each viral 
vector type has its characteristic features determining the mechanism of their entry, 
intracellular transport and expression (Davidson and Breakefield, 2003). 
Pseudotyping for lentiviral vectors (Page et al., 1990) or different combinations of 
capsid proteins for Adeno and Adeno-associated viruses (AAV) (Shevtsova et al., 
2005) as well directed molecular engineering of AAVs (Gray et al., 2011) allows 
changing the tropism to desirable cell types and creation of novel highly 
specialized vectors. Unfortunately the tropism of a particular viral vector cannot be 
predicted from results obtained in vitro on primary dissociated cells, it requires 
testing and titration of viral vector by in vivo applications (reviewed in Merienne et 
al., 2013). 
The viral vector for in vivo application should match several minimal terms: being 
able to transduce both dividing and non-dividing cells, have ability to cause little or 
no immune response and be non-cytotoxic, additionally it should have good 
spreading properties determined by viral particles size and their diffusion in the 
brain. Currently there are several viral vector systems available that in a grater or in 
a lesser extent facilitate astrocyte-specific gene delivery in vivo (reviewed in 
Merienne et al., 2013). 
4.5.4.1. Adeno-associated viral vectors for astrocytes 
Small, 20 nm in diameter, AAV particles have several advantages and limitations: 
they spread easily by diffusion in the brain and cause small or no immune 
response. On the other hand, their vector capacity is limited to 4.5-5 kb of genetic 
material (Concalves, 2005); the space that can accommodate a small promoter, 
couple of genes and a regulatory element (for instance internal ribosome entry 
site). AAV vectors are derived from naturally replication deficient viruses which 
can reproduce themselves only in a presence of adenoviral infection. Transgene 
expression delivered by AAV is mainly originated from episomal viral DNA 
(Nakai et al., 2001). 
The broad spectrum of natural AAV serotypes, chimeric vectors that combine 
features of different serotypes, and new AAV-based vectors generated by random 
mutagenesis with consequent tropism screening, underlie the flexibility of AAV 
based vector systems and make them promising vectors for clinical gene therapy. 
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Indeed, some AAVs have natural tropism to astroglial cells but transduction 
conditions and vector purification method should always be considered. Thus, 
AAV serotype 2 is able to efficiently target astrocytes in vitro but lack this ability 
in vivo (Gong et al., 2004). Systemic injection of AAV9 with CAG promoter 
results in neuronal and astrocytic expression in an age-dependent manner; in 
neonatal mice it has neuronal expression pattern (Klein et al., 2008; Foust et al., 
2009), but when administered to an adult mice expression was detected mainly in 
astrocytes (Foust et al., 2009). AAV4 and AAVrh43 in combination with CAG 
promoter can target astrocytes and ependymal cells in sub ventricular zone in vivo 
(Liu et al., 2005) that is very similar to results obtained by in vivo electroporation 
on neonatal rats with expression of CAG-EGFP cassette (Molotkov et al., 
unpublished observation). Chimeric AAVs, carrying the serotype 5 capsid proteins 
in a combination with hGFAP 2.2 kb and gfaABC1D promoters, were shown to be 
efficient for astrocyte transduction in vivo (Drinkut et al., 2012; Xie et al., 2010). 
Due to absence of immune response and their small size facilitating diffusion, 
sometimes even penetration through BBB in case of serotype 9, the AAV based 
vectors have a good potential to become carriers for future gene therapy 
approaches. 
4.5.4.2. Lentiviral vectors for astrocytes 
These relatively big enveloped viral particles of around 60-80 nm in diameter are 
derived from the human immunodeficiency virus 1 (HIV-1), they facilitate 
integration of transgene into the host cell genome and are able to escape immune 
response. The first packaging and efficient expression of the lentiviral vector in a 
rat brain was done by Naldini and colleagues who have demonstrated efficiency of 
lentiviral vector in transduction of neuronal cells (Naldini et al., 1996), that made 
this vector a popular tool for gene delivery into the brain. The vector integration 
into genome has a potential risk of insertional mutagenesis. In order to decrease 
risks and made these vectors suitable for gene therapy applications, integration-
deficient lentiviral vectors with an integrase mutation were developed (Wanisch 
and Yanez-Munoz, 2009).  
Ability of the lentiviral vectors to be pseudotyped with different viral glycoproteins 
provides additional flexibility in adjusting vector tropism that should also be 
considered with in vivo virus application. Thus, transduction of primary neuronal 
and glial co-cultures by vesicular stomatitis virus glycoprotein (VSVG) 
pseudotyped lentiviral vectors showed preferential expression in astrocytes 
(Englund et al., 2000). At the same time, application of the same VSVG-
pseudotyped vectors demonstrated their preference to infect neuronal cell rather 
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than astroglia (Naldini et al., 1996; Deglon et al., 2000). Pseudotyping lentiviral 
vector with Mokola virus or lymhocytic choriomeningitis virus (LCMV) envelope 
proteins results in preferable transduction of astrocytes in vivo (Colin et al., 2009; 
Cannon et al., 2011). However switching specificity by pseudotyping may result 
also in lowering virus stability and titer. Thus, both LCMV and Mokola 
pseudotyped lentiviral particles demonstrate decreased infectivity and lower titer 
when vector was produced and purified (Miletic et al., 2004; Colin et al., 2009). 
An interesting model that took an advantage of GFAP gene up-regulation in 
reactive astrocytes was developed. Using lentiviral vector with the GFAP promoter 
it was shown that expression can be up to 8 times higher under pathological 
conditions when astrocytes are activated compare to undamaged brain (Jakobsson 
et al., 2004). This model provides evidence that the promoter introduced by mean 
of lentiviral vector is regulated similarly to the endogenous promoter. It also opens 
a prospective strategy for using astrocytes as pathology-activated gene therapy 
targets. 
It is worth mentioning an elegant detargeting approach used by Colin and 
colleagues. In order to obtain nearly absolute astrocyte specificity they introduced 
an RNA sequence in the vector that suppresses gene expression in neurons by 
interaction with the neuron-specific micro RNA miR124 (Colin et al., 2009). This 
approach made possible astrocyte-specific expression from the lentiviral vector. 
4.5.4.3. Adenoviral vectors for astrocytes 
The surprisingly unpopular for in vivo CNS applications adenoviral vector has 
natural astroglial tropism, is an emerging tool to study astroglial cells and has 
variety of promoters determining its expression efficiency rather than specificity. 
Natural specificity of the adenoviral vector serotype 5 is caused by its ability to 
bind the coxsackie and adenoviral vector receptor (CAR). Those cells that do not 
express CAR on their surface cannot be targeted by the virus. This explains ability 
of astrocytes and also some dopaminergic neurons that express CAR to be 
transduced with adenoviral vectors (Lewis et al., 2010). 
The relatively big size (80-100 nm in diameter) of adenoviral particles and an 
absence of membrane envelope are limiting factors for diffusion of adenoviral 
particles when injected into the brain in vivo (Merienne et al., 2013). This problem 
of the vector is compensated by the fact that it can be applied locally to transduce a 
subset of cells within the well-defined spatial territory. Genetic material delivered 
by the vector is always episomal thus has no risk of insertional mutagenesis and 
provides transient expression of which productivity can be manipulated by the 
promoter. In that sense adenoviral vectors represent the most predictable delivery 
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system in which specificity is determined by natural tropism and in which 
efficiency can be adjusted by mean of different genetic insulating elements 
(promoters, enhancers, suppressors etc.) in the transgene. 
For twenty years adenoviral vectors have been used to transduce brain cells in vivo 
(Le Gal La Salle et al., 1993; Horellou et al., 1994). A novel packaging system 
(AdEasy system) that simplified vector production and improved its safety was 
developed by He and colleagues (He et al., 1998). The system allows rapid 
generation of replication deficient adenoviral vectors, which made them a popular 
tool for gene delivery to a variety of cell types. Recently, there have been several 
studies where successful in vivo application of adenoviral vectors, both in the 
neonatal and in the adult rodent brain, for astrocyte targeting in different brain 
regions was demonstrated (Gourine et al., 2010; Molotkov et al., in preparation 
(study III)). 
Adenoviral vectors are quite immunogenic when applied systemically in a blood 
flow. Thus, a strong immune response induced by adenoviral vectors was reported 
in humans when the effect of adenovirus based vaccine was studied (White et al., 
2011). On the other hand, such immunogenic properties could make adenovirus a 
promising vector for glioma therapy (Candolfi et al., 2006). 
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AIMS 
The major aim of the Thesis was to find out whether astrocytes in vivo are 
subjected to morphological changes and investigate if these changes are involved 
in the functionality of the neuronal network.  
The specific aims were to: 
1. Develop and validate in vitro a molecular genetically encodable tool for 
suppression of activity-dependent astroglial motility and fine morphological tracing 
(study I). 
2. Design and implement the gene delivery system that can facilitate astrocyte-
specific gene expression in rodent brain cortex in vivo (studies II and III). 
3. Find out if there are spontaneous morphological changes in astrocytes in vivo in 
the mouse brain and check the effect of their suppression on neuronal activity 
(study III). 
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METHODS 
All materials and methods used in this Thesis work are described in detail in the 
original publications (I-III). An overview of the methodological approaches and 
some highlights are provided below. 
Image analysis (I, II and III) 
For the summary of software solutions and methodological approaches for the 
image analysis and quantification used in the original studies I, II and III of the 
Thesis please see the table below. 
Software Developer Plug-ins used Main applications Study 
Cell-R Olympus 
 Image acquisition, calibration, 
quantification of Ca2+ responses and 
basic measurements 
I 
ImagePro 5.1 
Media 
Cybernetics 
Custom macros Application of filters, masking, 
quantification of filaments 
I 
Image J Open source 
Image calculator, 
built-in filter 
functions 
Binarization, background reduction, 
automatic and manual object tracing 
and quantification, image subtraction, 
image skeletonization 
I 
LSM image 
browser 
Zeiss 
 Image acquisition, calibration and 
basic analysis and measurements 
I and 
II 
Fiji Open source 
Image stabilizer, 3D 
drift correction, 
Maximum entropy 
threshold, Image 
calculator, Gaussian 
filter 
Image stabilization, drift correction, 
automatic thresholding, binarization, 
filtering, image subtraction and 
quantification 
III 
AutoQuant X3 
Media 
Cybernetics 
 3D non-blind deconvolution 
III 
Imaris Bitplane 
 Surface rendering, surface and 
volume quantification, masking III 
MatLab 
The 
MathWorks 
Custom scripts BOLD signal analysis; Fourier 
transform, filtering in frequency 
domain, quantification and 
representation of amplitude and 
phase maps 
III 
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Primary cortical astrocyte cultures (I) 
Cortical astrocytes were obtained from 2-3-day-old Wistar rats. After dissection 
and cell dissociation they were plated on glass bottom MatTek dishes precoated 
with poly-L-lysine or bovine plasma fibronectin at a density of 5x10
4
 cells per 
square centimeter. Cells were maintained in culture with high-glucose DMEM 
supplemented with 10% fetal bovine serum and antibiotics at +37 
o
C, 5% CO2.  
Plasmids were transfected into cultured astrocytes 2-3 days after plating using 
Lipofectamine reagent according to manufacturer recommendations. 
Photolysis of caged calcium and live cell imaging (I) 
Prior to the Ca
2+
 uncaging experiments cultured cortical astrocytes were loaded 
with caged 10 μM Ca2+ compound o-nitrophenyl (NP)-EGTA AM ester with 4 μM 
Fura-2 AM and 0.025% Pluronic F-127. The ultraviolet light beam (350-400 nm) 
flash (200 ms) from 150 W xenon lamp focused by Olympus PlanApo 60x/NA 
1.45 oil objective was used for the photolysis of NP-EGTA compound. Single 
wavelength (380 nm) Fura-2 signal and generated ΔF/F ratio (Grynkiewicz et al., 
1985) were used to evaluate effectiveness and the slope of Ca
2+
 responses and to 
perform calibration for estimation of peak intracellular concentrations of Ca
2+
 
caused by uncaging. 
For live cell imaging of astrocytes in culture the inverted Olympus Cell-R 
microscope equipped with Olympus PlanApo 60x/NA 1.45 oil objective and CCD 
camera was used. For fine morphological tracing the maximum camera resolution 
1344x1024 pixels was used. Frames with an exposure time of 500 ms were 
collected at a frequency of 1 to 0.2 Hz depending on particular experimental 
procedure. During imaging cells were maintained at +34 
o
C, 5% CO2 humidified 
atmosphere. 
Postnatal in vivo electroporation (II) 
Gene delivery using postnatal electroporation technique was done on newborn 
Wistar rat pups (1-2 days old). 50 to 100 nl of Plasmid solution with a high 
concentration of endotoxin-free DNA (1.5-3.0 mg/ml) was injected into the brain 
cortex through the pooled glass needle using stereotaxic manipulator and automatic 
microinjector. Plasmid injection was followed by the train of 5 rectangular 
electrical pulses (100-150 V/cm, 50 ms, 1 Hz). All surgical procedures were done 
under the isoflurane anesthesia (4% for induction, 2% for maintenance). Operated 
pups were recovered from anesthesia in warm chamber and returned to their 
mother within 15-20 minutes after operation was completed. 
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Preparation and in vivo application of adenoviral vectors (III) 
Serotype 5 adenoviral vectors were prepared according to AdEasy protocol (He et 
al., 1998). Expression cassettes containing LckGFP and abdProf-1-IRES-LckGFP 
were cloned into pShuttle vector and then transferred into pAdEasy-1 vector using 
homologous recombination approach. Viral particles were produced in 293A cell 
line and were subjected for 3-4 replication rounds in order to obtain high titer viral 
stock. Viral particles were concentrated and purified by high-speed centrifugation 
(175.000 g) in CsCl density gradient for 24 hours at +10 
o
C and then dialyzed 
versus sterile 1X PBS pH 7.4 supplemented with 5% glycerol using 20K MWCO 
membrane at +4 
o
C in order to get rid of CsCl in the virus preparation. Each viral 
vector batch was tested to contain no replication effective particles by reinfection 
of BHK21 cells. Virus titer was determined on 293A cells 24 hours post infection. 
For in vivo application the optimal dose for each adenoviral vector was adjusted by 
injecting serial virus dilutions (5-fold increment) into the adult mouse cortex 
through the sharped glass needle (Fig. 3A). The optimal topical virus application 
parameters for transduction of cortical astrocytes were determined and used further 
as follows: injection rate 1-2 nl/s, injection volume 500 nl, amount of virus in a 
range of 2*10
4
 to 5*10
4
 infectious units per injection. For all surgical procedures 
animals were anesthetized with isoflurane or with ketamine/xylazine mixture. 
Figure 3. Gene delivery to the 
rodent brain cortex. Sharped 
borosilicate glass needle used 
for topical virus injections 
(A).Neuronal cells in the rat 
neonatal pup visual cortex 
expressing GFP under the 
control of GFAP promter from 
the plasmid delivered using in 
vivo electroporation technique 
(B). 
 
In vivo two-photon microscopy through the cranial window (III) 
In vivo microscopy was done using Olympus FV1000MPE microscope equipped 
with Olympus 25X NA 1.05 XLPLN water objective and Mai Tai DeepSee mode 
locked tunable infrared laser. Prior every in vivo microscopy experiment 
70.000MW Texas Red – conjugated dextran was injected into the tail vein for 
fluorescent tracing of cortical vasculature. For both GFP and Texas Red the same 
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excitation beam of 860 nm was used, emitted light was filtered through 515-560 
BP filter and 590-650 BP filter for GFP and Texas Red respectively.   Image stacks 
were collected for astrocytes located at cortical layers 2/3 using the constant voxel 
dimensions of 0.167x0.167x0.5 microns (XYZ) and 5 minutes time increment. All 
animals were maintained anesthetized with ketamine/xylazine mixture during in 
vivo microscopy experiments. 
Intrinsic BOLD signal optical imaging (III) 
Images with a resolution of 1312x1082 pixels from primary visual cortex 
illuminated with red light (filter 630BP30) were collected using fast monochrome 
CMOS camera equipped with Nikkor 135 f/2 and Nikkor 50 f/1.2 objectives. 
Visual stimulus was presented by the vertical 5
o
-thick moving (0.2111 Hz) bright 
bar covering 90
o
 and 50
o
 of single eye visual field in horizontal and vertical planes 
respectively. Frames were collected in a rate of 10 Hz for 6 minutes in order to 
accumulate BOLD signal in a response to stimulation. During BOLD signal 
acquisition animals were maintained under mild isoflurane anesthesia (0.8-1.0%) 
with continuous monitoring of the respiration, heart beat rates and blood 
oxygenation level. 
Experimental animals (I, II and III) 
All the procedures were performed in accordance with the guidance for animal care 
(EU directive 2010/63/EU) and University of Helsinki animal practice. Animal 
license (ESAVI/2857/04.10.03/2012) was obtained from local authority 
(ELÄINKOELAUTKUNTA-ELLA). Newborn (1-3 days old) Wistar rat pups 
(study I and II) and adult (2-4 month old) C56BL mice (study III) were bred in the 
certified animal facility managed by the University of Helsinki. Animals were 
maintained in controlled temperature, humidity, constant 12/12 light-dark cycle 
and provided with ad libitum water and food. 
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RESULTS AND DISCUSSION 
1. The role of Profilin-1 in the activity-dependent outgrowth of 
astrocytic peripheral processes (study I). 
1.1 Actin turnover as the major mediator for Ca2+-dependent PAPs 
motility in vitro 
Even though actin dependent mechanisms for astrocytic morphological plasticity 
and for the outgrowth of PAPs was proposed by several studies (Reichenbach et 
al., 2010; Haber et al., 2006; Lavialle et al., 2011) there was no direct 
demonstration of actin in PAPs, and also its functional role in PAPs remodeling 
was not fully proved. On the other hand it is logical for actin to be involved in 
morphological plasticity of astrocytes and their peripheral processes since actin 
cytoskeleton remodeling is well known to be a driving force in cell edge motility 
and filopodia building process (Pollard and Borisy, 2003; Faix and Rottner, 2006). 
Using co-expression of membrane bound LckGFP (Benediktsson et al., 2005) and 
Lifeact-RFP (Riedl et al., 2008) in study I we demonstrated directly the presence of 
the filamentous actin within peripheral processes of cultured astrocytes (Study I, 
Fig. 1). This finding demonstrates that actin cytoskeleton has the potential to be 
involved in astrocytic morphological plasticity. The fact that filamentous actin is 
present within PAPs allowed us to suggest also that PAPs have a filopodia-like 
nature and their motility is regulated by the same fundamental mechanisms. 
Actin remodeling machinery is known to be differentially regulated in a variety of 
cellular compartments (reviewed by Pollard and Borisy, 2003). Since Profilin-1 is 
widely accepted as one of the major mediators of actin remodeling especially in 
filopodia formation and extension (Small, 1995; Witke et al., 2004; Faix and 
Rottner, 2006; Mattila and Lappalainen, 2008, Nemethova et al., 2008) it can also 
be involved in regulation of morphological changes in astrocytes and their 
peripheral processes. We next examined the functional role of Profilin-1 in the 
maintenance of astrocytic morphology, basal cell edge motility and activity-
dependent PAPs outgrowth using overexpression of actin binding deficient form of 
Profilin-1 (abdProf-1) (Suetsugu et al., 1999) in cultured astrocytes. We found that 
5-fold overexpression of abdProf-1 in transfected astrocytes, with regard to the 
basal Profilin-1 level in surrounding astrocytes, (Study I, Suppl. fig. 1) had no 
significant effect on the general complexity of cell morphology (Study I, Fig. 2) 
and basal motility rates of cell edge (Study I, Fig. 3). However, the effect of 
abdProf-1 overexpression has a significant impact on the activity-dependent 
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morphological plasticity of PAPs that was induced by Ca
2+
 uncaging in cultured 
astrocytes (Study I, Fig. 4). Control astrocytes did respond to the Ca
2+
 increase by 
the extensive PAPs outgrowth that resulted in doubling the PAPs density from 1 to 
2 PAPs per 10 µm of cell perimeter 400 second after the Ca
2+
 uncaging was 
performed. However, astrocytes that express abdProf-1 were not able to increase 
the PAPs density in a response to Ca
2+
 uncaging; despite they had the same basal 
level density of PAPs (Study I, Fig. 4G). Since the density of processes in the cell 
at the certain time point reflects the dynamic equilibrium between filopodia 
extension and retraction events we can assume that overexpression of abdProf-1 
prevented the shift of equilibrium towards the prevalence of PAPs formation over 
the PAPs retraction or in the other words damped the PAPs outgrowth rate to the 
basal level silencing the effect of Ca
2+
 stimulation. These findings demonstrate that 
first – astrocytes are able to form new filopodia-like processes in a response to the 
increase of intracellular Ca
2+
 and second – that Profilin-1 interaction with actin 
monomers is critical for the rapid extensive formation of astrocytic processes 
caused by the increase of intracellular Ca
2+
 but not for the maintenance of static 
morphology and base level motility of the cell edge. 
Profilin-1 binds to actin monomers, catalyzes the ADP-to-ATP exchange and 
facilitates shuttling of G-actin to the filamentous actin barbed ends promoting its 
polymerization (Pollard and Borisy, 2003). At the same time both actin and 
Profilin-1, as participants of the cyclic process of actin treadmilling, are subjected 
to feedback inhibition caused by monomer deficiency in case of extensive 
polymerization (Yarmola et al., 2009). Once we had found the damping effect of 
abdProf-1 overexpression on extensive de novo PAPs formation in Ca
2+
 stimulated 
astrocytes, we asked the question if there is any difference in properties of 
individual PAPs. Using time-lapse microscopy on astrocytes in culture we 
measured the kinetics for the appearance and extension of individual PAPs induced 
by Ca
2+
 uncaging. In addition to quantitative differences described above we found 
also qualitative differences between PAPs formed by control and abdProf-1 
expressing astrocytes. Indeed, the average outgrowth rate for PAPs formed by 
astrocytes expressing abdProf-1 was almost 2 times lower than in control 
astrocytes that expressed LckGFP only (1.89 µm/min in abdProf-1 versus 3.26 
µm/min in control). In addition to decreased outgrowth rates PAPs from astrocytes 
expressing abdProf-1 had on average significantly decreased maximum length 
(2.66 µm in abdProf-1 versus 4.61 µm in control) (Study I, Fig. 4H, I and J). These 
observations pointed out the Profilin-1 interaction with actin as a factor affecting 
the dynamics of activity-dependent PAPs outgrowth, which together with the 
presence of F-actin in PAPs suggests an actin-dependent mechanism underlying 
PAPs remodeling. 
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1.2 The novel tool to suppress activity-dependent PAPs motility 
In several recent studies cellular motility has been manipulated by affecting 
cytoskeleton-regulating signaling cascades on the level of small GTPases. Indeed, 
it was implemented as a photactivatable form of Rac that allowed control of cell 
migration (Wu et al., 2009) also as an overexpression of dominant negative form of 
Rac that was shown to suppress PAPs motility rates in organotypic slices (Nishida 
and Okabe, 2007). The main drawback for the GTPase-based approaches is caused 
by divergence of the Rac signaling and the side effects on other motility types like 
lamellipodia formation and general ability of the cell to migrate rather than to local 
activity-dependent morphological changes (Pollard and Borisy, 2003). In order to 
overcome these limitations and affect specifically astrocytic filopodia-like 
processes in activity-dependent manner, rather than cell migration in general, we 
utilized the Profilin-1 as a direct effector of actin polymerization which is well 
known for its role in filopodia building process (Witke, 2004; Faix and Rottner, 
2006; Mattila and Lappalainen, 2009) and was demonstrated to be critical 
especially for microspikes formation (Suetsugu et al., 1998; 1999). 
We propose that overexpression of abdProf-1 that was shown to suppress activity 
dependent outgrowth of PAPs in vitro (Study I, Fig. 4) can also be used as a 
genetically encodable tool to manipulate the morphological plasticity of astrocytes 
in vivo and study the effect of its suppression on neuronal function. However, in 
order to use the abdProf-1 in vivo the proper gene delivery system for astrocyte-
specific targeting should be implemented. 
2. Gene delivery to a postnatal rodent brain (studies II and III). 
2.1 Stereotaxic plasmid microinjection and electroporation on neonatal 
rat brain (study II) 
Gene delivery using electro-mediated nucleic acid transfer such as electroporation 
or iontophoresis is a powerful alternative to time consuming creation of transgenic 
animals or approaches based on viral vectors. Although the exact mechanism for 
nucleic acid entering the cell is not still revealed, electro-mediated nucleic acid 
transfer is widely used in CNS research (reviewed by De Vry et al., 2010(a)). The 
principal idea of the method is to inject genetic material such as DNA, RNA or 
shRNA into the brain and then facilitate its uptake by applying several electrical 
pulses that create directed electrical field and electro-driving force for charged 
nucleic acid molecules and also influence properties of cellular membranes. There 
are two main modifications for this technique; the one that is performed prenatally 
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by mean of surgical removal of the embryos from the uterus, plasmid injection into 
the lateral ventricles followed by electroporation (Saito and Nakatsuji, 2001; 
Tabata and Nakajima, 2001; Saito, 2006; Dixit et al., 2011; Sato et al., 2013) and 
another one that is performed on the different postnatal stages with a help of 
stereotaxic manipulator (Barnabe-Heider et al., 2008; Boutin et al., 2008; Borrell, 
2010; Molotkov et al., 2010 (study II); 2011; De la Rossa et al., 2013) or without it 
(Feliciano et al., 2013). Indeed, postnatal electroporation has such advantages as 
possibility to target spatially restricted region of interest regarding to the 
stereotaxic coordinates and overcome developmental compensatory effects of 
exogenous gene transfer. However, it also was limited mainly to the transduction of 
cells in a sub ventricular zone (SVZ). There are now several recent modifications 
of the postnatal electroporation technique allowing targeting of cells in brain 
regions outside the SVZ (Barnabe-Heider et al., 2008; Molotkov et al., 2010 (study 
II); De al Rossa et al., 2013). 
Using plasmid with ubiquitously expressed CAG promoter and EGFP as a reporter 
gene (Matsuda and Cepko, 2004; 2007) we modified the postnatal electroporation 
technique in order to apply it to non-SVZ brain regions such as cortical areas. We 
found that rapid injection (within 10 seconds) of the small volume (50 nl) of the 
highly concentrated plasmid (3 µg/µl) though the thin glass capillary (outlet 
diameter 20-30 µm) that was immediately followed by the application of 5 
rectangular (50 ms, 1 Hz) electrical pulses in a voltage controlled mode (120 V/cm) 
via forceps-like electrodes placed directly on the skull surface (Study II, movie) 
produces a well-defined pattern of EGFP expression in cortex and striatum (Study 
II, Fig. 1). We also found that the age between 1 and 3 postnatal days is the most 
suitable for the performance of the described method likely due to relatively low 
myelin content and not completely formed cranial bones which provide lower 
electrical resistance and thus the same applied voltage results in generation of 
higher current that improve transduction efficiency. Developed protocol also 
implemented application of the electro conductive gel for the best electrical contact 
between electrodes and skull bones and for the uniform distribution of the electrical 
field between the electrodes that was shown before to be one of the critical factors 
that can affect electroporation efficiency (Ivorra et al., 2008). 
The method described in study II facilitates spatially restricted expression of genes 
delivered in a form of plasmid DNA into neonatal brain parenchyma in vivo by 
mean of stereotaxic injection and subsequent electroporation. There was one 
previous study describing non-ventricular plasmid delivery in postnatal animals, 
where the targeting of the hippocampal dentate gyrus neuronal stem cells was 
shown on adult mice (Barnabe-Heider et al., 2008). In study II as well as in our 
following experiments (Molotkov et al., 2011) we met the problem caused by low 
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transduction efficiency in cortex and hippocampus that is likely a characteristic 
feature of non-dividing cells in the postnatal brain. The problem could be overcame 
by use of new-born pups as described in study II or facilitation of DNA uptake by 
application of complex-forming agents such as trans-cyclodextrane-1,2-diol that 
provides DNA entry to the nucleus in the non-dividing cell (De la Rossa et al., 
2013). It is also possible that recently proposed improvements for the 
electroporation procedure replacing voltage controlled pulses by current controlled 
pulses (De Vry et al., 2010(b)) and use of local needle-like electrodes generating 
higher electrical field density compared to plate electrodes (reviewed by De Vry et 
al., 2010(a)) may improve postnatal electroporation efficiency. 
The spatio-temporal restriction of the transgene expression is one of the main 
issues considered in genetic manipulation in vivo. It provides cell type specificity 
of expression, minimizing severe compensatory changes caused by prolonged 
expression during early developmental stages and allows expressing the transgene 
only in the defined region of interest within the brain. There are several approaches 
that could be implemented with electroporation techniques in order to get spatio-
temporal expression selectivity (reviewed by LoTurco et al., 2009; Huh et al., 
2010). The use of cell-type specific promoters is the easiest way to get expression 
in a certain subpopulations of cells in vitro or in case of creation of the transgenic 
animals, but can meet some limitations when naked DNA is applied in vivo by 
electroporation. Thus, if the expression of EGFP driven by ubiquitous CAG 
promoter appeared in different cell types (study II, Fig. 1) use of astroglia-specific 
GFAP promoter delivered into postnatal rat cortex by electroporation resulted in 
EGFP expression in neuronal cells rather than in astrocytes despite its expression 
specificity in vitro (Molotkov et al., 2011) (Fig. 3B). It is demonstrating the 
flexibility of GFAP promoter expression pattern which is likely caused by bacterial 
rather than eukaryotic methylation pattern of the plasmid DNA used for 
electroporation. This observation is a hinderance to validate transgene expression 
specificity in vivo when it is delivered in a form of naked bacterial plasmid DNA, 
whilst at the same time it promotes in vivo electroporation technique for studying 
regulatory elements influencing gene expression and effects of their epigenetic 
modifications such as methylation using synthetic constructs in vivo. 
 
2.2 Astrocyte-specific gene delivery using adenoviral vectors (study III). 
An intrinsic feature of adenoviruses is their ability to interact with CAR on the cell 
surface that determines a wide tropism of adenovirus-derived vectors (reviewed by 
Merienne et al., 2013). In the brain the CAR expression is restricted to astroglial 
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cells and dopaminergic neurons (Lewis et al., 2010) that proposes adenoviral 
vectors to be efficient and specific astrocyte transducers when they are applied 
topically in the brain areas lacking dopaminergic neurons. 
Using stereotaxic manipulator we applied topically to the adult mouse visual cortex 
the adenoviral vector of serotype 5 that expresses the membrane form of GFP as a 
fluorescent reporter under the control of CAG promoter. We checked ex vivo on 
fixed brain slices and in vivo through the cranial window distribution of GFP-
expressing cells, expression selectivity, transduction efficiency and expression 
timeline (Study III, Fig. 1). We found that although adenoviral particles are 
relatively big (80-100 nm in diameter) they can diffuse 200-500 nm away from the 
injection site causing efficient transduction in the total volume of 0.3-0.4 mm
3
 in 
mouse cortex. Also single injection of 2*10
4
 to 5*10
4
 viral particles produces an 
expression pattern occupying all cortical layers with densely packed GFP 
expressing cells suggesting high transfection rate. Well defined borders of the 
transduced zone are also suggests that effective expression could be achieved by 
few viral particle per cell and proving the high infectivity known for adenoviral 
vectors. Astrocyte labelling using immunostaining with anti-GFAP antibody on 
frozen brain sections derived from transduced animals showed that all GFP 
expressing cells were GFAP positive and that there are just a few non-transduced 
GFAP positive cells in the region. This demonstrates astrocyte specificity and 
further shows high transduction efficiency for the virus. Finally, we found that the 
virus can facilitate long term expression which can be used in a period from 1 week 
up to at least 6 weeks after the injection was done, providing an excellent timeline 
for most experimental paradigms. 
Although adenoviral vectors have been used to induce transgene expression in 
astrocytes both in organotypic slices (Nishida and Okabe, 2007) and in vivo for 
transduction of astroglia in the brainstem (Gourine et al., 2010) their effectiveness 
and specificity is under debate (Merienne et al., 2013). Relatively high 
immunogenic properties of adenovirus in comparison to other widely used vectors 
such as lenti and adeno-associated viruses as well as assumptions regarding their 
non-selectivity based on systemic adenovirus application (reviewed by Wirth et al., 
2013) stimulated the development of alternative viral vectors for astrocyte-specific 
genetic manipulations. Indeed, there are at least two viral vectors used on a par 
with adenoviruses that were shown to have high astrocytic expression specificity in 
vivo. It was shown that pseudotyping of lentiviral vectors with MOKOLA envelope 
protein can enhance their astrocytic tropism that could be further improved by 
insertion of mir124T neuronal silencer sequence in the vector genome (Colin et al., 
2009). Another alternative to facilitate astrocyte-specific targeting is based on the 
application of the AAV2/5 chimeric vector in combination with astroglia-specific 
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gfaABC1D promoter (Xie et al., 2010). Since AAV5 is known to have a wide 
tropism in the brain (Burger et al., 2004; Aschauer et al., 2013) which also varies 
depending on the developmental stage (Chakrabarty et al., 2013) it is possible to 
assume that astroglial expression of AAV2/5 is likely caused by the promoter 
rather than by virus transduction selectivity. 
Based on the data we have obtained for adenovirus-mediated astrocyte transduction 
and transgene expression we can conclude that the unfairly under evaluated 
adenoviral vectors can be used in basic research as well is in some clinical 
applications (reviewed by Wirth et al., 2013) as a safe episomal vector causing 
high levels of transient expression. Naturally, limited virus tropism in the brain 
allows fine tuning of the expression by use of different promoters without losing 
cell-type specificity. 
 
3. Motility of cortical astrocytes and neuronal function  
(study III). 
3.1 Astroglia spontaneous morphological changes are Profilin-1 
dependent. 
In primary cultures cortical astrocytes display both spontaneous and activity-
dependent morphological changes (see the study I). PAPs were also demonstrated 
to be motile at active synaptic terminals in acute brain slices (Hirrlinger et al., 
2004) and to be involved in morphological interplay with dendritic spines in 
organotypic brain slices (Haber et al., 2006; Nishida and Okabe, 2007). At the 
same time spontaneous as well as activity-dependent morphological plasticity in 
astrocytes in vivo has not been described yet. 
Using the adenoviral vector expressing a membrane form of GFP that allows high 
contrast labeling of PAPs we traced and quantified the rate of astrocytic motility at 
basal conditions, after induction of microstroke and with the overexpression of 
abdProf-1 (Study III, Fig. 3). We quantified the net changes of astrocyte peripheral 
processes and found that under resting conditions they are subjected to continuous 
relatively uniform morphological changes. This spontaneous motility results in 1.3-
1.5 % of astrocyte peripheral volume shift during 5 minutes interval. Our 
measurements consider the overall motility rates which unfortunately difficult to 
compare with the data obtained for the linear outgrowth rates or volume changes of 
individual astrocytic processes near the active synaptic terminals (Hirrlinger et al., 
2004) or during synaptogenesis (Haber et al., 2006). Interestingly, we found that 
overexpression of abdProf-1 caused suppression of spontaneous astrocyte motility 
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rates by 35-40% with respect to astrocytes expressing LckGFP only and used as a 
control. This finding demonstrates that similarly to astrocytes in culture (Study I) 
motility of PAPs in vivo is likely driven by actin dependent mechanism that is 
dependent on actin binding by Profilin-1. Although in vitro Profilin-1 
overexpression affects exclusively activity-dependent morphological changes of 
astrocytes and, particularly, rapid PAPs outgrowth induced by Ca
2+
 uncaging, in 
vivo it affects spontaneous motility of astrocytes. There are several key features of 
in vivo astrocyte physiology that can cause different sensitivity to the abdProf-1 
overexpression. First, astrocytes in vivo have remarkably increased 
compartmentalization due to their highly ramified structure, small internal PAPs 
volume limiting diffusion inside the PAP and thus, preventing local compensation 
effects. Second, increased external signal inputs caused by complex environment 
and also point-like localization of incoming signals sources, such as active synaptic 
terminals, that create highly localized gradients of neurotransmitters. Third, it 
should be considered that astrocytes in vivo are under the continuous baseline 
stimulation caused by background neuronal activity even in the anesthetized brain. 
Indeed, it would be extremely interesting to check whether spontaneous astrocytic 
motility differs in awake and anesthetized brain and what are the key mechanisms 
regulating motility of astrocytes in vivo. As a future development and improvement 
for the current study we propose the use of dual membrane and cytoplasmic 
fluorescent reporters that would allow more precise tracing of the surface of 
astrocyte together with its internal volume that  would further increase signal to 
noise ratio for the microscopic investigation of PAPs in vivo. 
 
3.2 Structure-functional interplay: the effect of suppressed astrocytic 
motility on neuronal processing. 
Astrocytes were recently shown to affect neuronal processing in several ways. 
They can control the synaptic activity and basal synaptic transmission (Araque et 
al., 1999; Perea et al., 2009; Fellin et al., 2009; Navarette and Araque, 2011), affect 
metabolic coupling between neurons and astroglia (Magistretti, 2006; Pellerin et 
al., 2007) and participate in local control of blood flow in an activity-dependent 
manner (Zonta et al., 2003; Mulligan and McVicar, 2004; Takano et al., 2006). At 
the same time some major aspects of glia-neuronal signaling are still controversial 
(Fiacco et al., 2007; Petravicz et al., 2008; Agulhon et al., 2008; Agulhon et al., 
2010). There are several potential sources for the controversy in the field of neuro-
glial research. First, it became evident recently that signaling linking astroglia and 
neurons is not as simple as was assumed before and can include some alternative 
  
59 
 
pathways as well as subjected for developmental changes (Sun et al., 2013; 
Shigetomi et al., 2013(b)) and thus, have to be revised. Second, different results 
were obtained under different experimental conditions (reviewed by Nedergaard 
and Verkhratsky, 2012). Additionally some experimental tools cannot be assumed 
as fully physiological relevant. Thus, Ca
2+
 uncaging differs from receptor mediated 
Ca
2+
 spike by its amplitude, kinetics and localization providing a good solution for 
general astrocyte activation but incomparable in physiological sense with glia-
neuronal signaling occurring in vivo (Wang et al., 2013). In this situation shading 
the light on the role of astrocytes in neuronal function using physiologically 
relevant tools in vivo is an extremely important issue. 
Existing in vitro and ex vivo data demonstrate that astrocytes are highly motile cells 
and can respond to a variety of external and internal stimuli by changing their 
morphology in a short term manner (reviewed by Reichenbach et al., 2010). 
Particularly it was shown in ultrastructural studies that PAPs and synapses are 
closely associated (Witcher et al., 2007), and there is a correlation between long-
term functional changes in synapses and their coverage by PAPs (Lushnikova et 
al., 2009). Using computational approaches to simulate changes in synaptic 
geometry it was predicted that PAP-synapse morphological interplay as well as 
GluT density in astrocytic compartment of the synapse could be the main 
determinants for synaptic efficacy and kinetics of postsynaptic neurotransmitter 
action (Freche et al., 2011) allowing us to assume that astroglial morphological 
changes could lead to functional changes in synapses. Several studies also 
demonstrated other possible molecular players involved in astrocytic 
morphological changes such as Ezrin, mGluRs, AQP4 and Kir4.1 (Lavialle et al., 
2011; Nagelhus et al., 2004). Indeed, there is accumulating evidence that PAPs 
structural changes are driven by actin dependent mechanism (Haber et al., 2006, 
Nishida and Okabe, 2007; Lavialle et al., 2011). 
We used abdProf-1 overexpression from the adenoviral vector, a molecular tool 
previously demonstrated to moderately suppress spontaneous PAPs motility in vivo 
(see part 3.1 and Study III, Fig. 3). By measuring BOLD signal propagation in 
response to visual stimulation as the readout of net neuronal activity in the primary 
visual cortex of adult anesthetized mice we tested whether suppressed astrocytic 
motility can affect neuronal processing. We found no signs of any distortions in 
activated cortical areas, magnitude maps or temporal phase maps as recorded from 
the visual cortices of animals transduced with control adenovirus expressing 
LckGFP or adenovirus expressing abdProf-1 (Study III, Fig. 4). In order to test 
whether optical fBOLD signal can be used for detecting functional changes in this 
experimental paradigm we quantified changes in fBOLD signal caused by laser 
induced thrombosis of single blood vessels and found that our acquisition and 
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analysis protocol is suitable for detecting functional changes caused by the 
microstroke (Study III, Fig. 5). These sets of data indicate that although 
microstroke caused functional changes in the cortex, the suppression of astrocytic 
motility by 35-40% (via abdProf-1) had no effect on net neuronal activity and 
corresponding oxygen metabolism in primary visual cortex of the adult 
anesthetized mouse. 
Despite that there are many reasons for astrocytic motility to be closely related 
with neuronal activity and metabolism, there are also aspects which can dissociate 
the link between morphological plasticity of astrocytes and synaptic function. 
Astrocytes are the first line to react on anesthesia since they have higher sensitivity 
for general anesthetics and lower threshold level to block their Ca
2+
 signalization 
(Schummers et al., 2008; Thrane et al., 2012). Silencing of astroglial Ca
2+
 signaling 
could also result in increased neuronal firing rates in the anesthetized brain (Thrane 
et al., 2012) which should cause metabolic changes and affect BOLD signal. 
Moreover developmental changes in the brain were shown to affect neuro-astrocyte 
crosstalk (Sun et al., 2013) and particularly caused decreased astrocytic sensitivity 
to general anesthetics in the developing brain (Hirase et al., 2004). Thus, 
investigating effect of suppressed astrocytic motility on net neuronal activity and 
synaptic function in the awake brain could be proposed as the next step to continue 
this study. It would also be useful to compare the obtained results with results 
gathered via more drastic PAPs motility suppression and also probe the functional 
effect of local astrocytic GluT blockade in awake and anesthetized brain. We also 
propose that the BOLD signal imaging could be accompanied with macro scale 
Ca
2+
 or voltage sensitive dye imaging in the cortex in order to separate neuronal 
activity and hemodynamic signal. Further, use of plasticity induction paradigms 
might reveal some changes caused by the suppression of astrocytic motility in the 
brain. 
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CONCLUSIONS 
We developed and validated on primary astroglial culture a molecular genetically 
encodable tool for suppression of activity-dependent PAPs motility and fine 
morphological tracing of astrocytic morphology (study I). 
We developed postnatal in vivo electroporation technique applicable for the rodent 
brain cortical areas (Study II) but found it to be unreliable for cases when absolute 
cell-type specificity is a prerequisite. We found out the gene delivery based on 
adenovirus serotype 5 with the CAG promoter to be a reliable astrocyte-specific 
gene delivery tool in vivo in the rodent brain cortex (study III). 
Results obtained in this work demonstrate that although astrocytes in vivo are 
subjected for spontaneous morphological changes, suppression of the astroglial 
motility rates by 35% does not cause detectable changes in functionality of the 
neuronal network in mouse visual cortex under light isoflurane anesthesia. We did 
not find the direct link between astrocytic motility and functional performance of 
the brain under particular conditions (Study III). 
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